{"items": "155", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/12/16/2997877/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20241216T210500", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Dec. 16, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.144549, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.582526", "ticker_sentiment_score": "0.209562", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin  ( IVIg )  or Plasma Exchange  ( PE )  in a Matched Patient Cohort for the Treatment of Guillain-Barr\u00e9 Syndrome  ( GBS ) ", "url": "https://www.globenewswire.com/news-release/2024/12/16/2997418/0/en/Annexon-Announces-Positive-Topline-Results-from-Real-World-Evidence-Study-Comparing-ANX005-Treatment-to-Intravenous-Immunoglobulin-IVIg-or-Plasma-Exchange-PE-in-a-Matched-Patient-C.html", "time_published": "20241216T123000", "authors": ["Annexon Biosciences"], "summary": "Real-World Evidence Study Strengthens the Body of Evidence Supporting ANX005 for Treatment of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.142662, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.157483", "ticker_sentiment_score": "0.074081", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/11/15/2982269/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20241115T215900", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Nov. 15, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.184176, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.577527", "ticker_sentiment_score": "0.264443", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/10/g41442047/annexon-presents-phase-2-vision-preservation-data-with-anx007-in-dry-amd-patients-with-less-advanc", "time_published": "20241022T000041", "authors": ["Globe Newswire"], "summary": "Enhanced protection of vision with ANX007 treatment in healthier eyes Greater preservation of EZ in the central fovea by ANX007 in patients with less advanced GA Pivotal Phase 3 ARCHER II Data Expected Second Half 2026 BRISBANE, Calif., Oct. 21, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.145564, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.137018", "ticker_sentiment_score": "0.146559", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting", "url": "https://www.globenewswire.com/news-release/2024/10/22/2966592/0/en/Annexon-Presents-Phase-2-Vision-Preservation-Data-with-ANX007-in-Dry-AMD-Patients-with-Less-Advanced-GA-at-the-American-Academy-of-Ophthalmology-2024-Meeting.html", "time_published": "20241022T000000", "authors": ["Annexon Biosciences"], "summary": "Enhanced protection of vision with ANX007 treatment in healthier eyes ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.157991, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.093653", "ticker_sentiment_score": "0.121422", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in GA at the Retina Society 57th Annual Meeting and 24th Euretina Congress - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/09/g40770858/annexon-to-present-phase-2-archer-data-on-protection-of-vision-and-photoreceptors-with-anx007-in-g", "time_published": "20240909T120000", "authors": ["Globe Newswire"], "summary": "Only Program that has Demonstrated Significant Vision Protection in Standard and Low Light Conditions and Significant Preservation of Photoreceptors in the Fovea Region Critical for Visual Acuity ARCHER II Phase 3 Pivotal Program in GA Underway with Data Expected Second Half 2026", "banner_image": "https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.108833, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.181819", "ticker_sentiment_score": "0.09295", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/08/16/2931713/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20240816T200500", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Aug. 16, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing novel complement therapies for neuroinflammatory diseases of the body, brain and eye, today announced that it has granted inducement to two new non-executive employees ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.205554, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.721785", "ticker_sentiment_score": "0.325401", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is Arbutus Biopharma  ( ABUS )  Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/2316975/is-arbutus-biopharma-abus-outperforming-other-medical-stocks-this-year", "time_published": "20240806T134012", "authors": ["Zacks Equity Research"], "summary": "Here is how Arbutus Biopharma (ABUS) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default197.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.261602, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ABUS", "relevance_score": "0.800175", "ticker_sentiment_score": "0.443113", "ticker_sentiment_label": "Bullish"}, {"ticker": "ANNX", "relevance_score": "0.478494", "ticker_sentiment_score": "0.21659", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/07/16/2914149/0/en/Annexon-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20240716T200500", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., July 16, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing novel therapies for neuroinflammatory diseases of the body, brain, and eye, today announced that it has granted inducement to a new non-executive employee under the terms ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.196338, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.730535", "ticker_sentiment_score": "0.31295", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is CareCloud  ( CCLD )  Outperforming Other Medical Stocks This Year?", "url": "https://www.zacks.com/stock/news/2301597/is-carecloud-ccld-outperforming-other-medical-stocks-this-year", "time_published": "20240715T134009", "authors": ["Zacks Equity Research"], "summary": "Here is how CareCloud, Inc. (CCLD) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default285.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.222406, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.464633", "ticker_sentiment_score": "0.278834", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CCLD", "relevance_score": "0.73545", "ticker_sentiment_score": "0.363373", "ticker_sentiment_label": "Bullish"}]}, {"title": "Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday - Bank of New York Mellon  ( NYSE:BK ) ", "url": "https://www.benzinga.com/news/24/07/39750475/bank-of-new-york-mellon-posts-upbeat-earnings-joins-archer-aviation-rivian-automotive-and-other-big", "time_published": "20240712T142717", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were higher, with the Nasdaq Composite index gaining around 100 points on Friday. Shares of The Bank of New York Mellon Corporation BK rose during Friday's session following better-than-expected quarterly financial results.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/07/12/Stocks-Photo-by-WHYFRAME-on-Shutterstock.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.363494, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "FWRD", "relevance_score": "0.175221", "ticker_sentiment_score": "0.469252", "ticker_sentiment_label": "Bullish"}, {"ticker": "QS", "relevance_score": "0.260189", "ticker_sentiment_score": "0.446038", "ticker_sentiment_label": "Bullish"}, {"ticker": "HIMS", "relevance_score": "0.175221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.175221", "ticker_sentiment_score": "0.469252", "ticker_sentiment_label": "Bullish"}, {"ticker": "BK", "relevance_score": "0.260189", "ticker_sentiment_score": "0.5445", "ticker_sentiment_label": "Bullish"}, {"ticker": "RIVN", "relevance_score": "0.260189", "ticker_sentiment_score": "0.193746", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RXRX", "relevance_score": "0.175221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUV", "relevance_score": "0.175221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.175221", "ticker_sentiment_score": "0.270426", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACHR", "relevance_score": "0.260189", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.175221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PACB", "relevance_score": "0.175221", "ticker_sentiment_score": "0.469252", "ticker_sentiment_label": "Bullish"}, {"ticker": "EYPT", "relevance_score": "0.175221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVGO", "relevance_score": "0.260189", "ticker_sentiment_score": "0.159827", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AUR", "relevance_score": "0.260189", "ticker_sentiment_score": "0.208735", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NTLA", "relevance_score": "0.175221", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/07/g39740960/annexon-to-present-additional-phase-2-data-showing-preservation-of-visual-function-and-structure-b", "time_published": "20240711T220909", "authors": ["Globe Newswire"], "summary": "Protective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as a Late-Breaking Oral Presentation Topline Phase 2 ARCHER Trial Results Will be Discussed as an Oral Presentation BRISBANE, Calif., July 11, 2024 ( GLOBE NEWSWIRE ) -- ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.077803, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.170275", "ticker_sentiment_score": "-0.014443", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting", "url": "https://www.globenewswire.com/news-release/2024/07/11/2912176/0/en/Annexon-to-Present-Additional-Phase-2-Data-Showing-Preservation-of-Visual-Function-and-Structure-by-ANX007-in-Geographic-Atrophy-at-the-42nd-ASRS-Annual-Scientific-Meeting.html", "time_published": "20240711T220900", "authors": ["Annexon Biosciences"], "summary": "Protective Effects of ANX007 on Visual Acuity and Vision Related Anatomical Measures in the Central Macula Will be Presented as a Late-Breaking Oral Presentation ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.070779, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.013547", "ticker_sentiment_label": "Neutral"}]}, {"title": "Are Medical Stocks Lagging Annexon  ( ANNX )  This Year?", "url": "https://www.zacks.com/stock/news/2294956/are-medical-stocks-lagging-annexon-annx-this-year", "time_published": "20240628T134011", "authors": ["Zacks Equity Research"], "summary": "Here is how Annexon, Inc. (ANNX) and CareCloud, Inc. (CCLD) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default277.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.22911, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.731515", "ticker_sentiment_score": "0.352486", "ticker_sentiment_label": "Bullish"}, {"ticker": "CCLD", "relevance_score": "0.461283", "ticker_sentiment_score": "0.326624", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Here's Why Annexon  ( ANNX )  Is a Great 'Buy the Bottom' Stock Now", "url": "https://www.zacks.com/stock/news/2294368/heres-why-annexon-annx-is-a-great-buy-the-bottom-stock-now", "time_published": "20240627T135502", "authors": ["Zacks Equity Research"], "summary": "After losing some value lately, a hammer chart pattern has been formed for Annexon (ANNX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default58.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.413559"}], "overall_sentiment_score": 0.214047, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.414559", "ticker_sentiment_score": "0.405734", "ticker_sentiment_label": "Bullish"}]}, {"title": "Treating Geographic Atrophy Remains a Tough Call for Ophthalmologists as They Voice Hesitancy to Prescribe Complement Inhibitors", "url": "https://www.benzinga.com/pressreleases/24/06/g39524015/treating-geographic-atrophy-remains-a-tough-call-for-ophthalmologists-as-they-voice-hesitancy-to-p", "time_published": "20240627T124955", "authors": ["Globe Newswire"], "summary": "Exton, Pennsylvania, June 27, 2024 ( GLOBE NEWSWIRE ) -- Prior to 2023, there was no treatment for GA, a progressive form of dry age-related macular degeneration that results in blindness. That changed in early 2023 when Apellis gained FDA approval for Syfovre, followed by Iveric Bio/Astellas' ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.202544, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BLTE", "relevance_score": "0.045396", "ticker_sentiment_score": "0.21708", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.045396", "ticker_sentiment_score": "0.21708", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JNJ", "relevance_score": "0.045396", "ticker_sentiment_score": "0.21708", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barr\u00e9 Syndrome at the 2024 PNS Annual Meeting", "url": "https://www.globenewswire.com/news-release/2024/06/25/2904155/0/en/Annexon-Presented-Additional-Positive-Phase-3-Results-for-ANX005-C1q-Targeted-Immunotherapy-in-Guillain-Barr%C3%A9-Syndrome-at-the-2024-PNS-Annual-Meeting.html", "time_published": "20240625T210000", "authors": ["Annexon Biosciences"], "summary": "ANX005-Treated Patients Demonstrated Faster and More Complete Recovery from Week 1 through Week 26 on Primary and Multiple Pre-Specified Endpoints ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.163667, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.13994", "ticker_sentiment_score": "0.148288", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barr\u00e9 Syndrome At 2024 PNS Annual Meeting - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39376518/annexon-to-present-pivotal-phase-3-data-on-early-and-durable-benefits-with-first-in-class-c1q-bloc", "time_published": "20240618T120000", "authors": ["Globe Newswire"], "summary": "Single Infusion of ANX005 Demonstrated Significant Improvements Across Multiple Functional and Prognostic Measures That Expedited Recovery in GBS Patients ANX005 Has Potential to be the First Targeted Therapy Approved for the Treatment of GBS BRISBANE, Calif., June 18, 2024 ( GLOBE NEWSWIRE ) -- ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.048166, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.244415", "ticker_sentiment_score": "-0.015175", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/06/17/2900001/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20240617T200500", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., June 17, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.138928, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.721785", "ticker_sentiment_score": "0.22225", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39365762/annexon-reports-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635-c-4", "time_published": "20240617T200500", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., June 17, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.174067, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.666827", "ticker_sentiment_score": "0.207367", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Is Annexon  ( ANNX )  Stock Outpacing Its Medical Peers This Year?", "url": "https://www.zacks.com/stock/news/2285310/is-annexon-annx-stock-outpacing-its-medical-peers-this-year", "time_published": "20240607T134009", "authors": ["Zacks Equity Research"], "summary": "Here is how Annexon, Inc. (ANNX) and Avalo Therapeutics, Inc. (AVTX) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default294.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.196368, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.747404", "ticker_sentiment_score": "0.332081", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AVTX", "relevance_score": "0.474958", "ticker_sentiment_score": "0.163712", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Announces Pricing of $125 Million Underwritten Public Offering", "url": "https://investingnews.com/annexon-announces-pricing-of-125-million-underwritten-public-offering/", "time_published": "20240606T033231", "authors": ["Investing News Network"], "summary": "Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced the pricing of its previously ...", "banner_image": "https://investingnews.com/media-library/image.gif?id=29654778&width=1200&height=600&coordinates=0%2C32%2C0%2C32", "source": "Investing News Network", "category_within_source": "n/a", "source_domain": "investingnews.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.999996"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.097344, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BR", "relevance_score": "0.045054", "ticker_sentiment_score": "0.093386", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.388879", "ticker_sentiment_score": "0.173168", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.089965", "ticker_sentiment_score": "0.108854", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Announces Pricing of $125 Million Underwritten Public Offering", "url": "https://www.globenewswire.com/news-release/2024/06/06/2894382/0/en/Annexon-Announces-Pricing-of-125-Million-Underwritten-Public-Offering.html", "time_published": "20240606T030400", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., June 05, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.576289"}, {"topic": "Financial Markets", "relevance_score": "0.999996"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.099746, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BR", "relevance_score": "0.04497", "ticker_sentiment_score": "0.098319", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.388209", "ticker_sentiment_score": "0.175606", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WFC", "relevance_score": "0.089797", "ticker_sentiment_score": "0.11402", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon  ( ANNX )  Up as Phase III Neuro Disorder Study Meets Goals", "url": "https://www.zacks.com/stock/news/2284172/annexon-annx-up-as-phase-iii-neuro-disorder-study-meets-goals", "time_published": "20240605T145700", "authors": ["Zacks Equity Research"], "summary": "Annexon (ANNX) jumps 31% after meeting the primary and key secondary endpoints with the low dose of its lead candidate, ANX005, in the phase III study for Guillain-Barre syndrome.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/2a/3899.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.890401"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.091636, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.43082", "ticker_sentiment_score": "0.217857", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CGEN", "relevance_score": "0.135602", "ticker_sentiment_score": "0.132494", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALXO", "relevance_score": "0.180124", "ticker_sentiment_score": "-0.025684", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANVS", "relevance_score": "0.180124", "ticker_sentiment_score": "-0.025698", "ticker_sentiment_label": "Neutral"}]}, {"title": "Wall Street Analysts Think Annexon  ( ANNX )  Could Surge 133.72%: Read This Before Placing a Bet", "url": "https://www.zacks.com/stock/news/2283995/wall-street-analysts-think-annexon-annx-could-surge-13372-read-this-before-placing-a-bet", "time_published": "20240605T135506", "authors": ["Zacks Equity Research"], "summary": "The consensus price target hints at a 133.7% upside potential for Annexon (ANNX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default260.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.226885, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.2842", "ticker_sentiment_score": "0.303521", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - DouYu Intl Hldgs  ( NASDAQ:DOYU ) ", "url": "https://www.benzinga.com/news/24/06/39181909/douyu-international-posts-q1-results-joins-annexon-dollar-tree-and-other-big-stocks-moving-lower-in", "time_published": "20240605T120739", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were higher this morning, with the Dow futures gaining around 50 points on Wednesday. Shares of DouYu International Holdings Limited DOYU fell in today's pre-market trading following first-quarter results.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/05/Image46.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.99977"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": -0.061594, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CMPS", "relevance_score": "0.268294", "ticker_sentiment_score": "0.372984", "ticker_sentiment_label": "Bullish"}, {"ticker": "DLTR", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.051105", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMC", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.130232", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOYU", "relevance_score": "0.507107", "ticker_sentiment_score": "-0.34221", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MDGL", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.502622", "ticker_sentiment_label": "Bearish"}, {"ticker": "ANNX", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.068357", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.130232", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNMD", "relevance_score": "0.268294", "ticker_sentiment_score": "-0.333474", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket - Stitch Fix  ( NASDAQ:SFIX ) ", "url": "https://www.benzinga.com/news/24/06/39178410/why-stitch-fix-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket", "time_published": "20240605T092725", "authors": ["Avi Kapoor"], "summary": "Shares of Stitch Fix, Inc. SFIX rose sharply in today's pre-market trading following better-than-expected third-quarter financial results. Stitch Fix reported quarterly losses of 18 cents per share which beat the analyst consensus estimate of losses of 24 cents by 25%.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/05/xrdDAFlJhBnMXo2-j1217490490970756473-t23.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.100275, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NDRA", "relevance_score": "0.20997", "ticker_sentiment_score": "0.336086", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MLGO", "relevance_score": "0.140896", "ticker_sentiment_score": "0.048765", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGRX", "relevance_score": "0.20997", "ticker_sentiment_score": "-0.074787", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFIX", "relevance_score": "0.277433", "ticker_sentiment_score": "0.113761", "ticker_sentiment_label": "Neutral"}, {"ticker": "WKME", "relevance_score": "0.20997", "ticker_sentiment_score": "0.236177", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VSTE", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.167745", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HPQ", "relevance_score": "0.070725", "ticker_sentiment_score": "0.281431", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.042634", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASNS", "relevance_score": "0.140896", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOBR", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.058051", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCM", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.137215", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFI", "relevance_score": "0.140896", "ticker_sentiment_score": "0.052319", "ticker_sentiment_label": "Neutral"}, {"ticker": "THMO", "relevance_score": "0.140896", "ticker_sentiment_score": "0.127617", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPS", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.081764", "ticker_sentiment_label": "Neutral"}, {"ticker": "JYD", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.065681", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGXX", "relevance_score": "0.140896", "ticker_sentiment_score": "0.322585", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FRES", "relevance_score": "0.140896", "ticker_sentiment_score": "0.135006", "ticker_sentiment_label": "Neutral"}, {"ticker": "HPE", "relevance_score": "0.140896", "ticker_sentiment_score": "0.341981", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MNMD", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.213688", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GDHG", "relevance_score": "0.140896", "ticker_sentiment_score": "-0.053855", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Announces Proposed Public Offering of Common Stock", "url": "https://www.globenewswire.com/news-release/2024/06/04/2893486/0/en/Annexon-Announces-Proposed-Public-Offering-of-Common-Stock.html", "time_published": "20240604T210600", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., June 04, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.998645"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.087744, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BR", "relevance_score": "0.046095", "ticker_sentiment_score": "0.079731", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.356225", "ticker_sentiment_score": "0.105318", "ticker_sentiment_label": "Neutral"}, {"ticker": "WFC", "relevance_score": "0.092036", "ticker_sentiment_score": "0.094727", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings - Designer Brands  ( NYSE:DBI ) ", "url": "https://www.benzinga.com/news/earnings/24/06/39168394/dow-surges-200-points-designer-brands-shares-plunge-following-q1-earnings", "time_published": "20240604T183230", "authors": ["Avi Kapoor"], "summary": "U.S. stocks turned higher toward the end of trading, with the Dow Jones gaining around 200 points on Tuesday. The Dow traded up 0.53% to 38,774.55 while the NASDAQ rose 0.29% to 16,877.87. The S&P 500 also rose, gaining, 0.25% to 5,296.54. Real estate shares rose by 1.3% on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/04/wall-street-subway-shutter.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.053268, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.145145", "ticker_sentiment_score": "0.249592", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NDRA", "relevance_score": "0.145145", "ticker_sentiment_score": "0.150788", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DBI", "relevance_score": "0.285526", "ticker_sentiment_score": "0.042502", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOBR", "relevance_score": "0.145145", "ticker_sentiment_score": "0.245852", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MLGO", "relevance_score": "0.145145", "ticker_sentiment_score": "0.108229", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQ", "relevance_score": "0.145145", "ticker_sentiment_score": "0.104478", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why is Annexon Stock Trading Higher On Tuesday? - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/general/biotech/24/06/39165249/mid-cap-firm-annexons-nerve-disorder-candidate-shows-promise-in-pivotal-late-stage-study", "time_published": "20240604T160620", "authors": ["Vandana Singh"], "summary": "On Tuesday, Annexon Inc ANNX released topline results from its Phase 3 trial in patients with Guillain-Barr\u00e9 syndrome ( GBS ) , an autoimmune condition in which the immune system attacks the nerves. As Guillain-Barre syndrome progresses, muscle weakness can turn into paralysis.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/04/ANNX.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.024024, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.401331", "ticker_sentiment_score": "-0.1234", "ticker_sentiment_label": "Neutral"}]}, {"title": "Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday - Saia  ( NASDAQ:SAIA ) ", "url": "https://www.benzinga.com/news/24/06/39161979/saia-annexon-core-scientific-and-other-big-stocks-moving-higher-on-tuesday", "time_published": "20240604T140859", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were mixed, with the Dow Jones index gaining around 20 points on Tuesday. Shares of Saia Inc SAIA rose sharply during today's pre-market trading session after the company reported an 18% increase in LTL shipments per workday in April. Saia shares jumped 12.3% to $452.00 on Tuesday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/04/xrdDAFqNaIkdw02-j153520640059868796-t230.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.303614, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SAIA", "relevance_score": "0.305058", "ticker_sentiment_score": "0.198042", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SKYW", "relevance_score": "0.305058", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.305058", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.305058", "ticker_sentiment_score": "0.537051", "ticker_sentiment_label": "Bullish"}, {"ticker": "FWRD", "relevance_score": "0.305058", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZQ", "relevance_score": "0.305058", "ticker_sentiment_score": "0.204805", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.305058", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZLAB", "relevance_score": "0.305058", "ticker_sentiment_score": "0.487484", "ticker_sentiment_label": "Bullish"}, {"ticker": "NEOG", "relevance_score": "0.305058", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.443626", "ticker_sentiment_score": "0.300291", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BOOT", "relevance_score": "0.305058", "ticker_sentiment_score": "0.649768", "ticker_sentiment_label": "Bullish"}, {"ticker": "ODFL", "relevance_score": "0.305058", "ticker_sentiment_score": "0.649768", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barr\u00e9 Syndrome - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39155240/annexon-announces-positive-topline-results-from-pivotal-phase-3-trial-for-first-in-class-c1q-block", "time_published": "20240604T110000", "authors": ["Globe Newswire"], "summary": "Single Infusion of ANX005 30 mg/kg Met Primary Endpoint, Delivering a Highly Statistically Significant and Clinically Meaningful 2.4-fold Improvement in GBS-DS vs. Placebo at Week 8, p=0.0058 ANX005 Demonstrated Early and Sustained Improvements in Key Secondary Endpoints Including Muscle ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.107765, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.208614", "ticker_sentiment_score": "0.075909", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - HealthEquity  ( NASDAQ:HQY ) ", "url": "https://www.benzinga.com/news/24/06/39153820/why-healthequity-shares-are-trading-higher-here-are-20-stocks-moving-premarket", "time_published": "20240604T095006", "authors": ["Avi Kapoor"], "summary": "Shares of Healthequity Inc HQY rose sharply in today's pre-market trading as the company reported better-than-expected first-quarter financial results. The company reported quarterly earnings of 80 cents per share which beat the analyst consensus estimate of 66 cents, according to data from ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/06/04/Movers.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.917436"}], "overall_sentiment_score": 0.227248, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ALBT", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.054861", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLGO", "relevance_score": "0.25168", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQNS", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.202391", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BARK", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.064959", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.25168", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HDB", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.013923", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYW", "relevance_score": "0.127456", "ticker_sentiment_score": "0.149132", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZQ", "relevance_score": "0.127456", "ticker_sentiment_score": "0.201935", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.190167", "ticker_sentiment_score": "0.126493", "ticker_sentiment_label": "Neutral"}, {"ticker": "LU", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.071448", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.127456", "ticker_sentiment_score": "0.173767", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NIVF", "relevance_score": "0.190167", "ticker_sentiment_score": "-0.040595", "ticker_sentiment_label": "Neutral"}, {"ticker": "HQY", "relevance_score": "0.25168", "ticker_sentiment_score": "0.390241", "ticker_sentiment_label": "Bullish"}, {"ticker": "YGMZ", "relevance_score": "0.190167", "ticker_sentiment_score": "0.223248", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PLTN", "relevance_score": "0.127456", "ticker_sentiment_score": "0.286315", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IBN", "relevance_score": "0.127456", "ticker_sentiment_score": "0.120564", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEXX", "relevance_score": "0.127456", "ticker_sentiment_score": "0.436453", "ticker_sentiment_label": "Bullish"}, {"ticker": "REGN", "relevance_score": "0.063933", "ticker_sentiment_score": "0.149173", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAPT", "relevance_score": "0.127456", "ticker_sentiment_score": "0.158514", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MBOT", "relevance_score": "0.127456", "ticker_sentiment_score": "-0.054861", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data", "url": "https://www.globenewswire.com/news-release/2024/06/03/2892620/0/en/Annexon-Biosciences-to-Host-Conference-Call-and-Webcast-to-Discuss-GBS-Phase-3-Data.html", "time_published": "20240603T203000", "authors": ["Annexon Biosciences"], "summary": "Call scheduled for Tuesday, June 4, 2024 at 8:30 a.m. ET Call scheduled for Tuesday, June 4, 2024 at 8:30 a.m. ET ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.04053, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.648497", "ticker_sentiment_score": "-0.172286", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Is Avalo Therapeutics  ( AVTX )  Stock Outpacing Its Medical Peers This Year?", "url": "https://www.zacks.com/stock/news/2277231/is-avalo-therapeutics-avtx-stock-outpacing-its-medical-peers-this-year", "time_published": "20240522T134009", "authors": ["Zacks Equity Research"], "summary": "Here is how Avalo Therapeutics, Inc. (AVTX) and Annexon, Inc. (ANNX) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default87.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.224704, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.478494", "ticker_sentiment_score": "0.350218", "ticker_sentiment_label": "Bullish"}, {"ticker": "AVTX", "relevance_score": "0.751437", "ticker_sentiment_score": "0.34602", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon  ( ANNX )  Loses -5.04% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner", "url": "https://www.zacks.com/stock/news/2275982/annexon-annx-loses--504-in-4-weeks-heres-why-a-trend-reversal-may-be-around-the-corner", "time_published": "20240520T133506", "authors": ["Zacks Equity Research"], "summary": "Annexon (ANNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default15.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.998356"}], "overall_sentiment_score": 0.180149, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.483888", "ticker_sentiment_score": "0.233263", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Biosciences to Present at the Bank of America Health Care Conference", "url": "https://www.globenewswire.com/news-release/2024/05/09/2878698/0/en/Annexon-Biosciences-to-Present-at-the-Bank-of-America-Health-Care-Conference.html", "time_published": "20240509T120000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., May 09, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.014535, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BAC", "relevance_score": "0.173333", "ticker_sentiment_score": "0.108788", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.81111", "ticker_sentiment_score": "0.024578", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting", "url": "https://www.globenewswire.com/news-release/2024/05/07/2877044/0/en/Annexon-Presents-New-Neuroprotection-Data-Showing-ANX007-Protects-Vision-and-Vision-Associated-Structures-in-Geographic-Atrophy-at-ARVO-2024-Annual-Meeting.html", "time_published": "20240507T163000", "authors": ["Annexon Biosciences"], "summary": "ANX007 demonstrated significant, broad-based protection from vision loss in foveal and non-foveal patients, and in low light settings ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.104904, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.180236", "ticker_sentiment_score": "0.059932", "ticker_sentiment_label": "Neutral"}]}, {"title": "RevOpsis Welcomes Dr. Emmett Cunningham to Strategic Advisory Board", "url": "https://www.prnewswire.com/news-releases/revopsis-welcomes-dr-emmett-cunningham-to-strategic-advisory-board-302135444.html", "time_published": "20240503T140000", "authors": ["RevOpsis"], "summary": "Internationally renowned ophthalmologist and investment leader joins to support advancement of disruptive ophthalmic treatments", "banner_image": "https://mma.prnewswire.com/media/2404225/Emmett_Cunningham_Headshot.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.365926"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.410465, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.050359", "ticker_sentiment_score": "0.310617", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CLAR", "relevance_score": "0.100518", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BX", "relevance_score": "0.150278", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon  ( ANNX )  to Report Q1 Earnings: What's in the Cards?", "url": "https://www.zacks.com/stock/news/2266131/annexon-annx-to-report-q1-earnings-whats-in-the-cards", "time_published": "20240501T141500", "authors": ["Zacks Equity Research"], "summary": "Annexon (ANNX) is expected to provide updates from the phase III study evaluating its lead candidate, ANX005, for the treatment of GBS in the first-quarter earnings release.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/c2/53795.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.999953"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.106666, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNY", "relevance_score": "0.137671", "ticker_sentiment_score": "-0.023677", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.547615", "ticker_sentiment_score": "0.219063", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ARGX", "relevance_score": "0.182851", "ticker_sentiment_score": "-0.004495", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.182851", "ticker_sentiment_score": "0.019761", "ticker_sentiment_label": "Neutral"}]}, {"title": "Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon  ( ANNX ) ", "url": "https://www.zacks.com/stock/news/2262171/down--4302-in-4-weeks-heres-why-you-should-you-buy-the-dip-in-annexon-annx", "time_published": "20240425T133506", "authors": ["Zacks Equity Research"], "summary": "Annexon (ANNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default215.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.154877, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.495015", "ticker_sentiment_score": "0.17936", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Are Medical Stocks Lagging Annexon  ( ANNX )  This Year?", "url": "https://www.zacks.com/stock/news/2256801/are-medical-stocks-lagging-annexon-annx-this-year", "time_published": "20240417T134010", "authors": ["Zacks Equity Research"], "summary": "Here is how Annexon, Inc. (ANNX) and Adma Biologics (ADMA) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default174.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.714479"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.291254, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ADMA", "relevance_score": "0.504646", "ticker_sentiment_score": "0.283421", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.78028", "ticker_sentiment_score": "0.450364", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon, Inc.  ( ANNX )  Falls More Steeply Than Broader Market: What Investors Need to Know", "url": "https://www.zacks.com/stock/news/2253705/annexon-inc-annx-falls-more-steeply-than-broader-market-what-investors-need-to-know", "time_published": "20240410T221519", "authors": ["Zacks Equity Research"], "summary": "In the latest trading session, Annexon, Inc. (ANNX) closed at $6.17, marking a -0.96% move from the previous day.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default200.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.173508, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.53784", "ticker_sentiment_score": "0.232002", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "What Makes Annexon  ( ANNX )  a New Buy Stock", "url": "https://www.zacks.com/stock/news/2248586/what-makes-annexon-annx-a-new-buy-stock", "time_published": "20240401T160009", "authors": ["Zacks Equity Research"], "summary": "Annexon (ANNX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default320.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": 0.309313, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.367865", "ticker_sentiment_score": "0.3597", "ticker_sentiment_label": "Bullish"}]}, {"title": "Wall Street Analysts Believe Annexon  ( ANNX )  Could Rally 101.12%: Here's is How to Trade", "url": "https://www.zacks.com/stock/news/2248420/wall-street-analysts-believe-annexon-annx-could-rally-10112-heres-is-how-to-trade", "time_published": "20240401T135505", "authors": ["Zacks Equity Research"], "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 101.1% in Annexon (ANNX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default229.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.226885, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.2842", "ticker_sentiment_score": "0.303521", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday - Cintas  ( NASDAQ:CTAS ) , Noah Holdings  ( NYSE:NOAH ) , PaySign  ( NASDAQ:PAYS ) ", "url": "https://www.benzinga.com/news/24/03/37959584/cintas-reports-upbeat-earnings-joins-paysign-noah-holdings-and-other-big-stocks-moving-higher-on-wed", "time_published": "20240327T140327", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday. Shares of Cintas Corporation CTAS rose sharply during Wednesday's session after the company reported better-than-expected third-quarter financial results and raised FY24 guidance.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/03/27/cintas_-_logo_copy.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Finance", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.857896"}], "overall_sentiment_score": 0.361176, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.202366", "ticker_sentiment_score": "0.376038", "ticker_sentiment_label": "Bullish"}, {"ticker": "KSS", "relevance_score": "0.202366", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.202366", "ticker_sentiment_score": "-0.185481", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PAYS", "relevance_score": "0.202366", "ticker_sentiment_score": "0.509934", "ticker_sentiment_label": "Bullish"}, {"ticker": "SMTC", "relevance_score": "0.202366", "ticker_sentiment_score": "0.688155", "ticker_sentiment_label": "Bullish"}, {"ticker": "STKS", "relevance_score": "0.202366", "ticker_sentiment_score": "0.179271", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LXRX", "relevance_score": "0.202366", "ticker_sentiment_score": "0.511259", "ticker_sentiment_label": "Bullish"}, {"ticker": "NCNO", "relevance_score": "0.202366", "ticker_sentiment_score": "0.36874", "ticker_sentiment_label": "Bullish"}, {"ticker": "NVCR", "relevance_score": "0.202366", "ticker_sentiment_score": "-0.078948", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.202366", "ticker_sentiment_score": "0.511259", "ticker_sentiment_label": "Bullish"}, {"ticker": "NUVB", "relevance_score": "0.202366", "ticker_sentiment_score": "0.179271", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SMR", "relevance_score": "0.202366", "ticker_sentiment_score": "0.511259", "ticker_sentiment_label": "Bullish"}, {"ticker": "CTAS", "relevance_score": "0.391923", "ticker_sentiment_score": "0.40123", "ticker_sentiment_label": "Bullish"}, {"ticker": "MRVL", "relevance_score": "0.202366", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones", "url": "https://www.globenewswire.com/news-release/2024/03/26/2852727/0/en/Annexon-Reports-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Key-Anticipated-Milestones.html", "time_published": "20240326T200500", "authors": ["Annexon Biosciences"], "summary": "Pivotal Phase 3 Data for ANX005 in Guillain-Barr\u00e9 Syndrome ( GBS ) Expected in Second Quarter ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.149431, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.159437", "ticker_sentiment_score": "0.0503", "ticker_sentiment_label": "Neutral"}]}, {"title": "Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday - FedEx  ( NYSE:FDX ) , Worthington Steel  ( NYSE:WS ) ", "url": "https://www.benzinga.com/news/24/03/37891941/worthington-steel-posts-upbeat-results-joins-summit-midstream-partners-fedex-and-other-big-stocks-mo", "time_published": "20240322T140847", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday. Shares of Worthington Steel, Inc. WS rose sharply during Friday's session as the company posted stronger-than-expected results for its third quarter.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/03/22/image12.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Earnings", "relevance_score": "0.682689"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Finance", "relevance_score": "0.25"}], "overall_sentiment_score": 0.380265, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "IMNM", "relevance_score": "0.21686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.109455", "ticker_sentiment_score": "0.240704", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FL", "relevance_score": "0.320279", "ticker_sentiment_score": "0.466559", "ticker_sentiment_label": "Bullish"}, {"ticker": "NOVA", "relevance_score": "0.21686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.21686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAC", "relevance_score": "0.109455", "ticker_sentiment_score": "0.269473", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TCRX", "relevance_score": "0.21686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMLP", "relevance_score": "0.21686", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLRY", "relevance_score": "0.21686", "ticker_sentiment_score": "0.533213", "ticker_sentiment_label": "Bullish"}, {"ticker": "FDX", "relevance_score": "0.21686", "ticker_sentiment_score": "0.343959", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WS", "relevance_score": "0.417995", "ticker_sentiment_score": "0.223038", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CGC", "relevance_score": "0.21686", "ticker_sentiment_score": "0.533213", "ticker_sentiment_label": "Bullish"}, {"ticker": "DNTH", "relevance_score": "0.21686", "ticker_sentiment_score": "0.43608", "ticker_sentiment_label": "Bullish"}, {"ticker": "OCGN", "relevance_score": "0.320279", "ticker_sentiment_score": "0.262661", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37799983/annexon-reports-inducement-grant-to-new-employee-under-nasdaq-listing-rule-5635-c-4", "time_published": "20240318T200500", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., March 18, 2024 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ANNX, a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement to a new ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.198347, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.759278", "ticker_sentiment_score": "0.270148", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Annexon  ( ANNX )  Might Surprise This Earnings Season", "url": "https://www.zacks.com/stock/news/2240542/why-annexon-annx-might-surprise-this-earnings-season", "time_published": "20240314T124000", "authors": ["Zacks Equity Research"], "summary": "Annexon (ANNX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99237"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.431247, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.898858", "ticker_sentiment_score": "0.542427", "ticker_sentiment_label": "Bullish"}]}, {"title": "ImmunoBrain Checkpoint Appoints Dr. Sanjay Keswani as Chief Executive Officer", "url": "https://www.prnewswire.com/news-releases/immunobrain-checkpoint-appoints-dr-sanjay-keswani-as-chief-executive-officer-302039635.html", "time_published": "20240122T130000", "authors": ["ImmunoBrain Checkpoint Inc."], "summary": "NEW YORK, Jan. 22, 2024 /PRNewswire/ -- ImmunoBrain Checkpoint Inc. ( ImmunoBrain ) , a clinical stage biopharmaceutical company developing innovative disease-modifying immune therapies to combat neurodegenerative diseases, today announced the appointment of Dr. Sanjay Keswani, MD, BSc, FRCP, as ...", "banner_image": "https://mma.prnewswire.com/media/2322444/ImmunoBrain_Checkpoint_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.284006, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.065685", "ticker_sentiment_score": "0.085332", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.065685", "ticker_sentiment_score": "0.085332", "ticker_sentiment_label": "Neutral"}]}, {"title": "Take the Zacks Approach to Beat the Market: Annexon, NVIDIA, Intuit in Focus", "url": "https://www.zacks.com/stock/news/2213270/take-the-zacks-approach-to-beat-the-market-annexon-nvidia-intuit-in-focus", "time_published": "20240122T115800", "authors": ["Abhinab Dasgupta"], "summary": "Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/93/534.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.972193"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.200125, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SHOP", "relevance_score": "0.067158", "ticker_sentiment_score": "0.089194", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.067158", "ticker_sentiment_score": "0.089194", "ticker_sentiment_label": "Neutral"}, {"ticker": "INTU", "relevance_score": "0.067158", "ticker_sentiment_score": "0.106254", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNTG", "relevance_score": "0.067158", "ticker_sentiment_score": "0.142413", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFH", "relevance_score": "0.067158", "ticker_sentiment_score": "0.246106", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.067158", "ticker_sentiment_score": "0.253167", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CYBR", "relevance_score": "0.067158", "ticker_sentiment_score": "0.108262", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.067158", "ticker_sentiment_score": "0.246106", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TSCO", "relevance_score": "0.067158", "ticker_sentiment_score": "0.061268", "ticker_sentiment_label": "Neutral"}, {"ticker": "FICO", "relevance_score": "0.100588", "ticker_sentiment_score": "0.112885", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSA", "relevance_score": "0.067158", "ticker_sentiment_score": "0.061268", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Annexon  ( ANNX )  Stock Outpacing Its Medical Peers This Year?", "url": "https://www.zacks.com/stock/news/2212118/is-annexon-annx-stock-outpacing-its-medical-peers-this-year", "time_published": "20240118T144003", "authors": ["Zacks Equity Research"], "summary": "Here is how Annexon, Inc. (ANNX) and Novartis (NVS) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default323.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.263827, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.745397", "ticker_sentiment_score": "0.419867", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon  ( ANNX )  Stock Rallies 156% in 3 Months: Here's How", "url": "https://www.zacks.com/stock/news/2211545/annexon-annx-stock-rallies-156-in-3-months-heres-how", "time_published": "20240117T160600", "authors": ["Zacks Equity Research"], "summary": "Annexon (ANNX) has rallied 156% in the past three months on plans to begin a registrational program for ANX007 in GA after reaching FDA alignment on the study's primary endpoint.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f2/4113.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.928769"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": 0.186906, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APLS", "relevance_score": "0.133593", "ticker_sentiment_score": "0.078278", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADMA", "relevance_score": "0.305328", "ticker_sentiment_score": "0.166205", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.498987", "ticker_sentiment_score": "0.300461", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBYI", "relevance_score": "0.220809", "ticker_sentiment_score": "0.161808", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session - Altimmune  ( NASDAQ:ALT ) , Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/news/24/01/36529043/harpoon-therapeutics-heron-therapeutics-and-other-big-stocks-moving-higher-in-mondays-pre-market-ses", "time_published": "20240108T103728", "authors": ["Avi Kapoor"], "summary": "U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday. Shares of Harpoon Therapeutics, Inc.HARP rose sharply in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/01/08/image13.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.623304"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.219886, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "CRON", "relevance_score": "0.320974", "ticker_sentiment_score": "0.594682", "ticker_sentiment_label": "Bullish"}, {"ticker": "HARP", "relevance_score": "0.465196", "ticker_sentiment_score": "0.495233", "ticker_sentiment_label": "Bullish"}, {"ticker": "SABR", "relevance_score": "0.320974", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.320974", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.320974", "ticker_sentiment_score": "-0.051467", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.465196", "ticker_sentiment_score": "0.421938", "ticker_sentiment_label": "Bullish"}, {"ticker": "BETR", "relevance_score": "0.320974", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.465196", "ticker_sentiment_score": "0.441744", "ticker_sentiment_label": "Bullish"}, {"ticker": "NXT(EXP20091224)", "relevance_score": "0.163909", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NXT", "relevance_score": "0.163909", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/24/01/g36526959/annexon-outlines-2024-priorities-with-late-stage-clinical-milestones-across-upstream-complement-po", "time_published": "20240108T010005", "authors": ["Globe Newswire"], "summary": "ANX005 Phase 3 Pivotal Data in Guillain-Barr\u00e9 Syndrome ( GBS ) On Track for First Half of 2024; Potential to be First Approved Treatment for GBS Patients in the U.S. ANX007 Global Pivotal Program in Geographic Atrophy ( GA ) to Initiate Mid-2024.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.140486, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.383616", "ticker_sentiment_score": "0.114677", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and Neurodegenerative Diseases", "url": "https://www.globenewswire.com/news-release/2024/01/08/2805026/0/en/Annexon-Outlines-2024-Priorities-with-Late-Stage-Clinical-Milestones-Across-Upstream-Complement-Portfolio-for-Autoimmune-Ophthalmic-and-Neurodegenerative-Diseases.html", "time_published": "20240108T010000", "authors": ["Annexon Biosciences"], "summary": "ANX005 Phase 3 Pivotal Data in Guillain-Barr\u00e9 Syndrome ( GBS ) On Track for First Half of 2024. Potential to be First Approved Treatment for GBS Patients in the U.S.", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.13832, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.377142", "ticker_sentiment_score": "0.161005", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "US Neurologists Optimistic Regarding the Huntington's Disease Treatment Pipeline, Emphasizing Halting Neurodegeneration as Leading Treatment Priority", "url": "https://www.benzinga.com/pressreleases/24/01/g36470593/us-neurologists-optimistic-regarding-the-huntingtons-disease-treatment-pipeline-emphasizing-haltin", "time_published": "20240103T144651", "authors": ["Globe Newswire"], "summary": "EXTON, PA, Jan. 03, 2024 ( GLOBE NEWSWIRE ) -- Huntington's disease ( HD ) could be called the perfect storm of neurodegenerative diseases.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.021837, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PTCT", "relevance_score": "0.04823", "ticker_sentiment_score": "0.057266", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.04823", "ticker_sentiment_score": "0.057266", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.096283", "ticker_sentiment_score": "0.060902", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCNX", "relevance_score": "0.04823", "ticker_sentiment_score": "0.057266", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVE", "relevance_score": "0.096283", "ticker_sentiment_score": "0.060902", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOREX:UZS", "relevance_score": "0.04823", "ticker_sentiment_score": "0.057266", "ticker_sentiment_label": "Neutral"}]}, {"title": "$1M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying - SRAX  ( OTC:SRAX ) , Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/12/36424252/1m-bet-on-this-healthcare-stock-check-out-these-3-penny-stocks-insiders-are-aggressively", "time_published": "20231229T113646", "authors": ["Avi Kapoor"], "summary": "The Dow Jones index closed higher by over 50 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/29/image37.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.161647"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}], "overall_sentiment_score": 0.264786, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SRAX", "relevance_score": "0.472338", "ticker_sentiment_score": "0.292849", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "VRME", "relevance_score": "0.570165", "ticker_sentiment_score": "0.533559", "ticker_sentiment_label": "Bullish"}, {"ticker": "ANNX", "relevance_score": "0.570165", "ticker_sentiment_score": "0.307379", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/12/27/2801303/0/en/Annexon-Biosciences-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html", "time_published": "20231227T113000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that Douglas Love, president and ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.014345, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.899125", "ticker_sentiment_score": "-0.02527", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36394912/annexon-biosciences-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conference", "time_published": "20231227T113000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Dec. 27, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ANNX a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that Douglas Love, president and chief ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.0119, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.844077", "ticker_sentiment_score": "-0.020609", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Gains 100 Points; CarMax Earnings Top Views - Clene  ( NASDAQ:CLNN ) , Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/news/earnings/23/12/36350420/nasdaq-gains-100-points-carmax-earnings-top-views", "time_published": "20231221T192303", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76. The S&P 500 also rose, gaining, 0.50% to 4,721.72. Materials shares jumped by 0.7% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/21/image20.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.058145, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LGVN", "relevance_score": "0.123844", "ticker_sentiment_score": "-0.077903", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOOK", "relevance_score": "0.123844", "ticker_sentiment_score": "0.227132", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PBLA", "relevance_score": "0.184834", "ticker_sentiment_score": "0.352363", "ticker_sentiment_label": "Bullish"}, {"ticker": "AVGO", "relevance_score": "0.06211", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNN", "relevance_score": "0.184834", "ticker_sentiment_score": "0.109269", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.184834", "ticker_sentiment_score": "0.112789", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGI", "relevance_score": "0.123844", "ticker_sentiment_score": "0.320759", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.244723", "ticker_sentiment_score": "0.140637", "ticker_sentiment_label": "Neutral"}, {"ticker": "GILD", "relevance_score": "0.06211", "ticker_sentiment_score": "0.197164", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today? - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/general/biotech/23/12/36342487/why-is-complement-mediated-focused-annexon-stock-trading-higher-today", "time_published": "20231221T160718", "authors": ["Vandana Singh"], "summary": "On Wednesday, Annexon Inc ANNX reported results from the Phase 1 single ascending dose ( SAD ) and multiple ascending dose ( MAD ) healthy volunteer study of ANX1502 that targets the active form of C1s responsible for propagating classical pathway activation in association with C1q.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/12/21/annx.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.014471, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APLS", "relevance_score": "0.209365", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.647216", "ticker_sentiment_score": "0.147927", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway", "url": "https://markets.businessinsider.com/news/stocks/annexon-reports-phase-1-results-for-anx1502-its-oral-small-molecule-inhibitor-of-the-classical-complement-pathway-1032917565", "time_published": "20231221T001907", "authors": ["markets.businessinsider.com"], "summary": "Target Levels of Active Drug Achieved in Healthy Volunteers with Oral Twice-Daily Dosing; Supportive Impact on Pharmacodynamic Biomarker of Complement Activity ANX1502 Generally Well Tolerated Across Cohorts with No Serious Adverse Events", "banner_image": "https://ml.globenewswire.com/media/YWMzYTk4NzktNTU0OC00ZjY2LWIxMmUtMDBjMmNiOWJlZGM2LTEyMDE2NDU=/tiny/Annexon-Biosciences.png", "source": "Business Insider", "category_within_source": "GoogleRSS", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.114918, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.309973", "ticker_sentiment_score": "0.155656", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock", "url": "https://www.globenewswire.com/news-release/2023/12/20/2799681/0/en/Annexon-Announces-Pricing-of-125-0-Million-Underwritten-Public-Offering-of-Common-Stock.html", "time_published": "20231220T222700", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Dec. 20, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( NASDAQ: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.986564"}], "overall_sentiment_score": 0.057017, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BR", "relevance_score": "0.05257", "ticker_sentiment_score": "0.083627", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.490323", "ticker_sentiment_score": "0.078557", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36335370/annexon-outlines-global-registrational-program-for-anx007-in-geographic-atrophy-with-fda-alignment", "time_published": "20231220T221053", "authors": ["Globe Newswire"], "summary": "Alignment with FDA on Best Corrected Visual Acuity \u2265 15-Letter Loss as Primary Outcome Measure - Representing the Highest Value Outcome to Patients and Physicians ARCHER II, a Global Sham-Controlled Trial Supporting a Potentially Faster Path to Registration, Expected to Initiate in Mid-2024", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.130298, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.198873", "ticker_sentiment_score": "0.091041", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint", "url": "https://www.globenewswire.com/news-release/2023/12/20/2799678/0/en/Annexon-Outlines-Global-Registrational-Program-for-ANX007-in-Geographic-Atrophy-with-FDA-Alignment-on-Vision-Preservation-as-Primary-Endpoint.html", "time_published": "20231220T221000", "authors": ["Annexon Biosciences"], "summary": "Alignment with FDA on Best Corrected Visual Acuity \u2265 15-Letter Loss as Primary Outcome Measure - Representing the Highest Value Outcome to Patients and Physicians ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.132889, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.222096", "ticker_sentiment_score": "0.128505", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway", "url": "https://www.globenewswire.com/news-release/2023/12/20/2799677/0/en/Annexon-Reports-Phase-1-Results-for-ANX1502-its-Oral-Small-Molecule-Inhibitor-of-the-Classical-Complement-Pathway.html", "time_published": "20231220T220800", "authors": ["Annexon Biosciences"], "summary": "Target Levels of Active Drug Achieved in Healthy Volunteers with Oral Twice-Daily Dosing. Supportive Impact on Pharmacodynamic Biomarker of Complement Activity ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.119815, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.28387", "ticker_sentiment_score": "0.149929", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2023/12/18/2798116/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20231218T210100", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Dec. 18, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that it has granted inducement ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.163475, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.805127", "ticker_sentiment_score": "0.272456", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference", "url": "https://www.globenewswire.com/news-release/2023/11/22/2785030/0/en/Annexon-Biosciences-to-Participate-in-the-6th-Annual-Evercore-ISI-HealthCONx-Conference.html", "time_published": "20231122T210100", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devastating inflammatory-related diseases, today announced that Douglas Love, president ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.014337, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.183895", "ticker_sentiment_score": "-0.003012", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.896455", "ticker_sentiment_score": "-0.025237", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Participate in the 6th Annual Evercore ISI HealthCONx Conference - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g35924972/annexon-biosciences-to-participate-in-the-6th-annual-evercore-isi-healthconx-conference", "time_published": "20231122T210100", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": -0.011923, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EVR", "relevance_score": "0.174587", "ticker_sentiment_score": "-0.001449", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.87744", "ticker_sentiment_score": "-0.02088", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results", "url": "https://www.globenewswire.com/news-release/2023/11/13/2778849/0/en/Annexon-Reports-Significant-Progress-with-its-Priority-Programs-and-Third-Quarter-2023-Financial-Results.html", "time_published": "20231113T113000", "authors": ["Annexon Biosciences"], "summary": "Company Prioritizes Greatest Near-term Value-Driving Programs: ANX005 for Guillain-Barr\u00e9 Syndrome ( GBS ) , ANX007 for Geographic Atrophy ( GA ) and First-in-Kind Complement Small Molecule, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.177811, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.240291", "ticker_sentiment_score": "0.148292", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Participate in 2023 Jefferies London Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/11/09/2777120/0/en/Annexon-Biosciences-to-Participate-in-2023-Jefferies-London-Healthcare-Conference.html", "time_published": "20231109T113000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Nov. 09, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for people living with devasting inflammatory-related diseases, today announced that Douglas Love, president and ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.035582, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.90178", "ticker_sentiment_score": "0.062878", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Receives PRIME Designation from the EMA for ANX007 for the Treatment of Geographic Atrophy", "url": "https://www.globenewswire.com/news-release/2023/10/24/2765415/0/en/Annexon-Receives-PRIME-Designation-from-the-EMA-for-ANX007-for-the-Treatment-of-Geographic-Atrophy.html", "time_published": "20231024T103000", "authors": ["Annexon Biosciences"], "summary": "PRIME Designation Granted Based on Phase 2 ARCHER Trial Results, which Showed Meaningful Preservation of Visual Function in Patients with Geographic Atrophy ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.137927, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.222582", "ticker_sentiment_score": "0.139941", "ticker_sentiment_label": "Neutral"}]}, {"title": "Open-Angle Glaucoma Market Size and Share to Accelerate Substantially by 2032, Predicts DelveInsight | Key Companies in the Market - SPARC, AbbVie, Ocuphire, Santen, Glaukos, Ocular Therapeutix, VivaVision Biotech, MediPrint Ophthalmics", "url": "https://www.prnewswire.com/news-releases/open-angle-glaucoma-market-size-and-share-to-accelerate-substantially-by-2032-predicts-delveinsight--key-companies-in-the-market---sparc-abbvie-ocuphire-santen-glaukos-ocular-therapeutix-vivavision-biotech-mediprint-ophth-301954523.html", "time_published": "20231012T210100", "authors": ["DelveInsight Business Research", "LLP"], "summary": "Open-Angle Glaucoma Market Size and Share to Accelerate Substantially by 2032, Predicts DelveInsight | Key ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.166016, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "QBIO", "relevance_score": "0.025651", "ticker_sentiment_score": "0.030768", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNPHF", "relevance_score": "0.025651", "ticker_sentiment_score": "0.030768", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.025651", "ticker_sentiment_score": "0.036754", "ticker_sentiment_label": "Neutral"}, {"ticker": "GKOS", "relevance_score": "0.025651", "ticker_sentiment_score": "0.080746", "ticker_sentiment_label": "Neutral"}, {"ticker": "INM", "relevance_score": "0.025651", "ticker_sentiment_score": "0.030768", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABBV", "relevance_score": "0.051276", "ticker_sentiment_score": "0.079668", "ticker_sentiment_label": "Neutral"}, {"ticker": "NICXF", "relevance_score": "0.051276", "ticker_sentiment_score": "0.069713", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUP", "relevance_score": "0.051276", "ticker_sentiment_score": "0.069713", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAER", "relevance_score": "0.051276", "ticker_sentiment_score": "0.069713", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUL", "relevance_score": "0.10234", "ticker_sentiment_score": "0.070883", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPHLF", "relevance_score": "0.025651", "ticker_sentiment_score": "0.080746", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Announces Clinical and Regulatory Progress for ANX005 Pivotal Program in Guillain-Barr\u00e9 Syndrome  ( GBS ) ", "url": "https://www.globenewswire.com/news-release/2023/10/10/2757271/0/en/Annexon-Announces-Clinical-and-Regulatory-Progress-for-ANX005-Pivotal-Program-in-Guillain-Barr%C3%A9-Syndrome-GBS.html", "time_published": "20231010T103000", "authors": ["Annexon Biosciences"], "summary": "ANX005 Granted Orphan Drug Designation by the European Medicines Agency for the Treatment of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.056097, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.216215", "ticker_sentiment_score": "0.012224", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Participate in the 2023 Cantor Global Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/09/19/2745419/0/en/Annexon-Biosciences-to-Participate-in-the-2023-Cantor-Global-Healthcare-Conference.html", "time_published": "20230919T103000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.155784, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.880186", "ticker_sentiment_score": "0.269991", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Biosciences to Participate in the 2023 Cantor Global Healthcare Conference - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/09/g34720671/annexon-biosciences-to-participate-in-the-2023-cantor-global-healthcare-conference", "time_published": "20230919T103000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Sept. 19, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.146464, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.860826", "ticker_sentiment_score": "0.268003", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Down -28.96% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon, Inc.  ( ANNX ) ", "url": "https://www.zacks.com/stock/news/2146543/down--2896-in-4-weeks-heres-why-you-should-you-buy-the-dip-in-annexon-inc-annx", "time_published": "20230908T133506", "authors": ["Zacks Equity Research"], "summary": "Annexon, Inc. (ANNX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default158.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.206276, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.483888", "ticker_sentiment_score": "0.284173", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "InflaRx  ( IFRX )  Skyrockets 110% in Six Months: Here's Why", "url": "https://www.zacks.com/stock/news/2143927/inflarx-ifrx-skyrockets-110-in-six-months-heres-why", "time_published": "20230901T183800", "authors": ["Zacks Equity Research"], "summary": "Shares of InflaRx (IFRX) show an upward trajectory after it obtained authorization for its first-ever marketed drug, which is approved for the treatment of critically ill COVID-19 patients.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/71/1337.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.99489"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.048238, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.236972", "ticker_sentiment_score": "0.09091", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIP", "relevance_score": "0.348919", "ticker_sentiment_score": "0.236151", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANVS", "relevance_score": "0.236972", "ticker_sentiment_score": "0.064178", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIF", "relevance_score": "0.060085", "ticker_sentiment_score": "-0.014082", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results", "url": "https://www.globenewswire.com/news-release/2023/08/07/2719531/0/en/Annexon-Highlights-Recent-Pipeline-and-Business-Progress-and-Reports-Second-Quarter-2023-Financial-Results.html", "time_published": "20230807T103000", "authors": ["Annexon Biosciences"], "summary": "ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with Geographic Atrophy. Company to Engage Regulatory Agencies to Determine Optimal Path Forward ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.127244, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.331765", "ticker_sentiment_score": "0.127536", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g33530872/annexon-reports-inducement-grant-to-new-employee-under-nasdaq-listing-rule-5635-c-4", "time_published": "20230802T200100", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Aug. 02, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.325186, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.746257", "ticker_sentiment_score": "0.518349", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Presents ARCHER Trial Results at ASRS 2023 Highlighting Potential of ANX007 as a Differentiated Treatment for Geographic Atrophy", "url": "https://www.globenewswire.com/news-release/2023/07/30/2714521/0/en/Annexon-Presents-ARCHER-Trial-Results-at-ASRS-2023-Highlighting-Potential-of-ANX007-as-a-Differentiated-Treatment-for-Geographic-Atrophy.html", "time_published": "20230730T160000", "authors": ["Annexon Biosciences"], "summary": "Additional analyses support consistent protection from vision loss ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.06999, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.267664", "ticker_sentiment_score": "0.037246", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Presents ARCHER Trial Results at ASRS 2023 Highlighting Potential of ANX007 as a Differentiated Treatment for Geographic Atrophy - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/07/g33460789/annexon-presents-archer-trial-results-at-asrs-2023-highlighting-potential-of-anx007-as-a-different", "time_published": "20230730T160000", "authors": ["Globe Newswire"], "summary": "Additional analyses support consistent protection from vision loss Annexon to engage with regulatory agencies to determine optimal path forward for ANX007 Company to hold investor conference call on Monday, July 31, 2023, at 1:30 p.m. PT / 4:30 p.m. ET", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.067622, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.226477", "ticker_sentiment_score": "0.08008", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer", "url": "https://www.globenewswire.com/news-release/2023/07/27/2711977/0/en/Annexon-Biosciences-Strengthens-Leadership-Team-with-Appointment-of-Jamie-Dananberg-M-D-as-Chief-Medical-Officer.html", "time_published": "20230727T103000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., July 27, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( \"Annexon\" ) ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.314216, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.692465", "ticker_sentiment_score": "0.375752", "ticker_sentiment_label": "Bullish"}, {"ticker": "UBX", "relevance_score": "0.081276", "ticker_sentiment_score": "0.041868", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/07/g33414017/annexon-biosciences-strengthens-leadership-team-with-appointment-of-jamie-dananberg-m-d-as-chief-m", "time_published": "20230727T103000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., July 27, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( \"Annexon\" ) ANNX, a clinical-stage biopharmaceutical company developing a new class of complement-based medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.303338, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.630286", "ticker_sentiment_score": "0.357439", "ticker_sentiment_label": "Bullish"}, {"ticker": "UBX", "relevance_score": "0.079392", "ticker_sentiment_score": "0.041733", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon to Report ARCHER Phase 2 Trial Results in Geographic Atrophy at ASRS 2023", "url": "https://www.globenewswire.com/news-release/2023/07/24/2709360/0/en/Annexon-to-Report-ARCHER-Phase-2-Trial-Results-in-Geographic-Atrophy-at-ASRS-2023.html", "time_published": "20230724T103000", "authors": ["Annexon Biosciences"], "summary": "Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ET Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ET ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.04233, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.822984", "ticker_sentiment_score": "0.167853", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Geographic Atrophy Market to Boost Significantly, Assesses DelveInsight | Key Companies Active in the Domain - Novartis, Annexon, Apellis, Ionis, Astellas, Gyroscope, Genentech, Aviceda, Iveric Bio", "url": "https://www.prnewswire.com/news-releases/geographic-atrophy-market-to-boost-significantly-assesses-delveinsight--key-companies-active-in-the-domain---novartis-annexon-apellis-ionis-astellas-gyroscope-genentech-aviceda-iveric-bio-301865699.html", "time_published": "20230628T210100", "authors": ["DelveInsight Business Research", "LLP"], "summary": "Geographic Atrophy Market to Boost Significantly, Assesses DelveInsight | Key Companies Active in the Domain ... PR ...", "banner_image": "https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.090361, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "KOD", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.087948", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTLK", "relevance_score": "0.025845", "ticker_sentiment_score": "-0.055936", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSD", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.087948", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLS", "relevance_score": "0.051663", "ticker_sentiment_score": "0.002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISEE", "relevance_score": "0.051663", "ticker_sentiment_score": "0.002", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPMF", "relevance_score": "0.025845", "ticker_sentiment_score": "0.007551", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.077426", "ticker_sentiment_score": "-0.01029", "ticker_sentiment_label": "Neutral"}, {"ticker": "IONS", "relevance_score": "0.051663", "ticker_sentiment_score": "0.002", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBX", "relevance_score": "0.025845", "ticker_sentiment_score": "-0.055936", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPT", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.087948", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZN", "relevance_score": "0.077426", "ticker_sentiment_score": "-0.075581", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGM", "relevance_score": "0.077426", "ticker_sentiment_score": "0.00206", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGNX", "relevance_score": "0.025845", "ticker_sentiment_score": "-0.055936", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.051663", "ticker_sentiment_score": "-0.087948", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon  ( ANNX )  Stock Down More Than 50% Last Week: Here's Why", "url": "https://www.zacks.com/stock/news/2101444/annexon-annx-stock-down-more-than-50-last-week-heres-why", "time_published": "20230530T144000", "authors": ["Zacks Investment Research"], "summary": "Annexon (ANNX) announces mixed top-line results from the phase II study of ANX007 in patients with geographic atrophy.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/67/1932.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": 0.05089, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APLS", "relevance_score": "0.154455", "ticker_sentiment_score": "0.088588", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISEE", "relevance_score": "0.229872", "ticker_sentiment_score": "0.314994", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.303175", "ticker_sentiment_score": "-0.085406", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Drops Sharply; Best Buy Earnings Top Expectations - Annexon  ( NASDAQ:ANNX ) , Digital Turbine  ( NASDAQ:APPS ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32582243/crude-oil-drops-sharply-best-buy-earnings-top-expectations", "time_published": "20230525T183908", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining more than 200 oints on Thursday. The Dow traded down 0.02% to 32,793.29 while the NASDAQ rose 1.78% to 12,706.89. The S&P 500, also rose, gaining, 0.96% to 4,154.71. Information technology shares rose by 4.4% ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/crude_oil_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.021662, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.175009", "ticker_sentiment_score": "0.166951", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIOC", "relevance_score": "0.1172", "ticker_sentiment_score": "-0.091859", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMR", "relevance_score": "0.1172", "ticker_sentiment_score": "0.094111", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.1172", "ticker_sentiment_score": "0.173208", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BBY", "relevance_score": "0.175009", "ticker_sentiment_score": "-0.040112", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.1172", "ticker_sentiment_score": "0.00807", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.1172", "ticker_sentiment_score": "0.161884", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WLDS", "relevance_score": "0.1172", "ticker_sentiment_score": "0.281992", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KBNT", "relevance_score": "0.175009", "ticker_sentiment_score": "0.461286", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.058759", "ticker_sentiment_score": "-0.099781", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Surges 1.5%; NVIDIA Shares Jump Following Strong Q1 Results - Annexon  ( NASDAQ:ANNX ) , Digital Turbine  ( NASDAQ:APPS ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32579047/nasdaq-surges-1-5-nvidia-shares-jump-following-strong-q1-results", "time_published": "20230525T160218", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 1.5% on Thursday. The Dow traded down 0.20% to 32,733.60 while the NASDAQ rose 1.53% to 12,674.85. The S&P 500, also rose, gaining, 0.63% to 4,141.09. Information technology shares rose by 3.7% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/stock_market_up_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.905476"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.06467, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NVDA", "relevance_score": "0.337811", "ticker_sentiment_score": "0.345408", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIOC", "relevance_score": "0.115787", "ticker_sentiment_score": "-0.091418", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZUO", "relevance_score": "0.115787", "ticker_sentiment_score": "0.172377", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMR", "relevance_score": "0.115787", "ticker_sentiment_score": "0.09366", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.115787", "ticker_sentiment_score": "0.008028", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.115787", "ticker_sentiment_score": "0.161108", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WLDS", "relevance_score": "0.115787", "ticker_sentiment_score": "0.28067", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KBNT", "relevance_score": "0.172919", "ticker_sentiment_score": "0.458075", "ticker_sentiment_label": "Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.058047", "ticker_sentiment_score": "-0.0997", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Shares of Annexon Are Plummeting Thursday", "url": "https://www.fool.com/investing/2023/05/25/why-shares-of-annexon-are-plummeting-thursday/", "time_published": "20230525T155231", "authors": ["Jim Halley"], "summary": "Mixed trial results on a geographic atrophy eye drug led investors to sell the biotech stock.", "banner_image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F733846%2Fmoney-rain-dividend-payments-receiving-cash-1.jpg&op=resize&h=340", "source": "Motley Fool", "category_within_source": "n/a", "source_domain": "www.fool.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.200868, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ISEE", "relevance_score": "0.126784", "ticker_sentiment_score": "0.116041", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.47672", "ticker_sentiment_score": "0.320793", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why Annexon  ( ANNX )  Stock Is Getting Hammered - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/news/23/05/32576633/why-annexon-annx-stock-is-getting-hammered", "time_published": "20230525T153507", "authors": ["Henry Khederian"], "summary": "Annexon Inc ANNX shares are trading lower by some 57.16% to $2.96 Thursday morning. The company announced topline results from its ARCHER Phase 2 trial of ANX007 in patients with geographic atrophy ( GA ) . Annexon says ANX007 was generally well tolerated as both a monthly and ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/doctor-2568481.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.033079, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.925854", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Drops 100 Points; US GDP Tops Estimates - Annexon  ( NASDAQ:ANNX ) , Digital Turbine  ( NASDAQ:APPS ) ", "url": "https://www.benzinga.com/news/earnings/23/05/32574777/dow-drops-100-points-us-gdp-tops-estimates", "time_published": "20230525T134627", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining over 1% on Thursday. Following the market opening Thursday, the Dow traded down 0.34% to 32,687.15 while the NASDAQ rose 1.36% to 12,653.95. The S&P 500, also rose, gaining, 0.49% to 4,135.24.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/stock_market_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": 0.081618, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.131284", "ticker_sentiment_score": "0.024656", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.259037", "ticker_sentiment_score": "0.577724", "ticker_sentiment_label": "Bullish"}, {"ticker": "LWLG", "relevance_score": "0.131284", "ticker_sentiment_score": "0.182197", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BMR", "relevance_score": "0.131284", "ticker_sentiment_score": "0.099021", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.259037", "ticker_sentiment_score": "0.526563", "ticker_sentiment_label": "Bullish"}, {"ticker": "ANNX", "relevance_score": "0.131284", "ticker_sentiment_score": "0.008523", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.131284", "ticker_sentiment_score": "0.1703", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.065866", "ticker_sentiment_score": "-0.180831", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.065866", "ticker_sentiment_score": "-0.180831", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why Annexon  ( ANNX )  Stock Is Tumbling Today - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/general/biotech/23/05/32568850/annexons-eye-disease-drug-reports-mixed-trial-results-will-focus-on-planned-late-stage-study", "time_published": "20230525T121227", "authors": ["Vandana Singh"], "summary": "Annexon Inc ANNX announced topline results from its ARCHER Phase 2 trial of ANX007 in patients with geographic atrophy ( GA ) . ANX007 was not statistically significant compared to pooled sham, the comparator, at 12 months in patients with geographic atrophy.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/25/aapharma.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}], "overall_sentiment_score": -0.1728, "overall_sentiment_label": "Somewhat-Bearish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.740604", "ticker_sentiment_score": "-0.157162", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Annexon Biosciences to Participate in the 22nd Annual Needham Virtual Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/04/11/2644185/0/en/Annexon-Biosciences-to-Participate-in-the-22nd-Annual-Needham-Virtual-Healthcare-Conference.html", "time_published": "20230411T103000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., April 11, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.209044, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.874686", "ticker_sentiment_score": "0.35742", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones", "url": "https://www.globenewswire.com/news-release/2023/03/06/2620852/0/en/Annexon-Reports-Fourth-Quarter-and-Year-End-2022-Financial-Results-and-Reiterates-Anticipated-Milestones.html", "time_published": "20230306T113000", "authors": ["Annexon Biosciences"], "summary": "Initial Clinical Data from Phase 2 Trial of ANX007 in Patients with Geographic Atrophy On-track for ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.099682, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.366061", "ticker_sentiment_score": "0.130637", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Participate in the 43rd Annual Cowen Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/02/27/2615857/0/en/Annexon-Biosciences-to-Participate-in-the-43rd-Annual-Cowen-Healthcare-Conference.html", "time_published": "20230227T113000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Feb. 27, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.206786, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.874686", "ticker_sentiment_score": "0.353806", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/02/g30950897/annexon-reports-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635-c-4", "time_published": "20230216T210500", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Feb. 16, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.299414, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.746257", "ticker_sentiment_score": "0.483172", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2023/01/17/2590531/0/en/Annexon-Reports-Inducement-Grant-to-New-Employee-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20230117T213000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Jan. 17, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.333773, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.748842", "ticker_sentiment_score": "0.51896", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.benzinga.com/pressreleases/23/01/g30451541/annexon-reports-inducement-grant-to-new-employee-under-nasdaq-listing-rule-5635-c-4", "time_published": "20230117T213000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Jan. 17, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}], "overall_sentiment_score": 0.316624, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.730954", "ticker_sentiment_score": "0.50599", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises", "url": "https://www.globenewswire.com/news-release/2023/01/08/2584729/0/en/Annexon-Highlights-Strategic-Focus-to-Advance-Four-Flagship-Complement-Programs-through-Late-Stage-Development-and-Progress-Across-Three-Therapeutic-Franchises.html", "time_published": "20230108T140000", "authors": ["Annexon Biosciences"], "summary": "Mid-stage and Pivotal Trials of ANX005, ANX007 and ANX1502 Poised to Achieve Numerous Catalysts in Multiple Disease Indications ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.130782, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.372027", "ticker_sentiment_score": "0.148518", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNOW", "relevance_score": "0.017573", "ticker_sentiment_score": "0.027852", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/01/g30323708/annexon-highlights-strategic-focus-to-advance-four-flagship-complement-programs-through-late-stage", "time_published": "20230108T140000", "authors": ["Globe Newswire"], "summary": "Mid-stage and Pivotal Trials of ANX005, ANX007 and ANX1502 Poised to Achieve Numerous Catalysts in Multiple Disease Indications Well-Capitalized with Operating Runway into 2025 Company to Present Pipeline Updates at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 7:30 a.m. PT", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}], "overall_sentiment_score": 0.133075, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.352223", "ticker_sentiment_score": "0.181715", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DNOW", "relevance_score": "0.017357", "ticker_sentiment_score": "0.026098", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Appoints Industry Veteran, Dr. Rick Artis, as Chief Scientific Officer to Support the Advancement and Expansion of Complement-focused Portfolio", "url": "https://www.globenewswire.com/news-release/2023/01/06/2584298/0/en/Annexon-Appoints-Industry-Veteran-Dr-Rick-Artis-as-Chief-Scientific-Officer-to-Support-the-Advancement-and-Expansion-of-Complement-focused-Portfolio.html", "time_published": "20230106T113000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.328898, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.68145", "ticker_sentiment_score": "0.493496", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Appoints Industry Veteran, Dr. Rick Artis, as Chief Scientific Officer to Support the Advancement and Expansion of Complement-focused Portfolio - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/01/g30307799/annexon-appoints-industry-veteran-dr-rick-artis-as-chief-scientific-officer-to-support-the-advance", "time_published": "20230106T113000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Jan. 06, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.320198, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.672864", "ticker_sentiment_score": "0.488192", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon to Present at 41st Annual J.P. Morgan Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2023/01/04/2582723/0/en/Annexon-to-Present-at-41st-Annual-J-P-Morgan-Healthcare-Conference.html", "time_published": "20230104T113000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Jan. 04, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.209044, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.874686", "ticker_sentiment_score": "0.35742", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon to Present at 41st Annual J.P. Morgan Healthcare Conference - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/23/01/g30270433/annexon-to-present-at-41st-annual-j-p-morgan-healthcare-conference", "time_published": "20230104T113000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Jan. 04, 2023 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ANNX, a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that Douglas ...", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.195471, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.855251", "ticker_sentiment_score": "0.351275", "ticker_sentiment_label": "Bullish"}]}, {"title": "Wall Street Analysts Think Annexon, Inc.  ( ANNX )  Could Surge 241%: Read This Before Placing a Bet", "url": "https://www.zacks.com/stock/news/2024227/wall-street-analysts-think-annexon-inc-annx-could-surge-241-read-this-before-placing-a-bet", "time_published": "20221201T145527", "authors": ["Zacks Investment Research"], "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 241.4% in Annexon, Inc. (ANNX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default225.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.234067, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.284861", "ticker_sentiment_score": "0.366893", "ticker_sentiment_label": "Bullish"}]}, {"title": "How Much Upside is Left in Annexon, Inc.  ( ANNX ) ? Wall Street Analysts Think 246%", "url": "https://www.zacks.com/stock/news/2018429/how-much-upside-is-left-in-annexon-inc-annx-wall-street-analysts-think-246", "time_published": "20221115T145516", "authors": ["Zacks Investment Research"], "summary": "The mean of analysts' price targets for Annexon, Inc. (ANNX) points to a 246.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default28.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.54554"}], "overall_sentiment_score": 0.22956, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.286864", "ticker_sentiment_score": "0.359395", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Reports Third Quarter 2022 Financial Results and Plans to Provide Updates on Complement Therapeutic Portfolio in January 2023", "url": "https://www.globenewswire.com/news-release/2022/11/03/2547351/0/en/Annexon-Reports-Third-Quarter-2022-Financial-Results-and-Plans-to-Provide-Updates-on-Complement-Therapeutic-Portfolio-in-January-2023.html", "time_published": "20221103T103000", "authors": ["Annexon Biosciences"], "summary": "Company to provide portfolio updates across autoimmune, neurodegeneration and ophthalmology therapeutic franchises in early January ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.614606"}], "overall_sentiment_score": 0.171819, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.340194", "ticker_sentiment_score": "0.228482", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2022/09/16/2517825/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20220916T200100", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Sept. 16, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.314586, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.767202", "ticker_sentiment_score": "0.49683", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Annexon  ( NASDAQ:ANNX ) ", "url": "https://www.benzinga.com/pressreleases/22/09/g28902001/annexon-reports-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635-c-4", "time_published": "20220916T200100", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Sept. 16, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.297275, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.748842", "ticker_sentiment_score": "0.483733", "ticker_sentiment_label": "Bullish"}]}, {"title": "BioCryst Pharmaceuticals  ( NASDAQ:BCRX )  - BioCryst Names Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan Arnold Chief Medical Officer", "url": "https://www.benzinga.com/pressreleases/22/09/g28872104/biocryst-names-dr-bill-sheridan-chief-development-officer-and-appoints-dr-ryan-arnold-chief-medica", "time_published": "20220914T200110", "authors": ["Globe Newswire"], "summary": "RESEARCH TRIANGLE PARK, N.C., Sept. 14, 2022 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. today announced that Dr. Bill Sheridan will become chief development officer and will focus on advancing the company's significant pipeline of development candidates.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.204364, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCRX", "relevance_score": "0.196877", "ticker_sentiment_score": "0.121399", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.06623", "ticker_sentiment_score": "0.044129", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.06623", "ticker_sentiment_score": "0.044129", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.06623", "ticker_sentiment_score": "0.044129", "ticker_sentiment_label": "Neutral"}]}, {"title": "BioCryst Names Dr. Bill Sheridan Chief Development Officer and Appoints Dr. Ryan Arnold Chief Medical Officer", "url": "https://www.globenewswire.com/news-release/2022/09/14/2516384/29446/en/BioCryst-Names-Dr-Bill-Sheridan-Chief-Development-Officer-and-Appoints-Dr-Ryan-Arnold-Chief-Medical-Officer.html", "time_published": "20220914T200100", "authors": ["Inc.", "BioCryst Pharmaceuticals"], "summary": "RESEARCH TRIANGLE PARK, N.C., Sept. 14, 2022 ( GLOBE NEWSWIRE ) -- BioCryst Pharmaceuticals, Inc. today announced that Dr. Bill Sheridan will become chief development officer and will focus on advancing the company's significant pipeline of development candidates.", "banner_image": "https://ml.globenewswire.com/Resource/Download/8b033909-1a3c-4811-b07b-fe03b12e00d2?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.215955, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BCRX", "relevance_score": "0.138863", "ticker_sentiment_score": "0.100018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.069697", "ticker_sentiment_score": "0.045268", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.069697", "ticker_sentiment_score": "0.045268", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.069697", "ticker_sentiment_score": "0.045268", "ticker_sentiment_label": "Neutral"}]}, {"title": "Co. Advancing Drug Class With Broad Potential", "url": "https://www.investorideas.com/news/2022/biotech/09142Advancing-Drug-Class.asp", "time_published": "20220914T160429", "authors": [], "summary": "September 14, 2022 ( Investorideas.com Newswire ) This developer of C1q-targeting therapeutics, with a catalyst-rich 18 months ahead, warrants analyst coverage, noted a BTIG report.", "banner_image": "https://www.streetwisereports.com/images/FVPAHeMVUAAqtCh.jpg", "source": "Investor Ideas", "category_within_source": "n/a", "source_domain": "www.investorideas.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.120287, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.083687", "ticker_sentiment_score": "-0.034947", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLN", "relevance_score": "0.125242", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.041901", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.041901", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.041901", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2022/08/17/2500377/0/en/Annexon-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20220817T200500", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., Aug. 17, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.303831, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.775204", "ticker_sentiment_score": "0.483492", "ticker_sentiment_label": "Bullish"}]}, {"title": "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.benzinga.com/pressreleases/22/08/g28541480/annexon-reports-inducement-grants-to-new-employees-under-nasdaq-listing-rule-5635-c-4", "time_published": "20220817T200500", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., Aug. 17, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.918141"}], "overall_sentiment_score": 0.236618, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.471718", "ticker_sentiment_score": "0.374621", "ticker_sentiment_label": "Bullish"}]}, {"title": "ANNX: Insider Buying Sends Annexon Stock Higher. But Does That Make It a Buy?", "url": "https://stocknews.com/news/annx-vrtx-amgn-biib-insider-buying-sends-annexon-stock-higher-but-does-that-make/", "time_published": "20220721T131546", "authors": [], "summary": "Annexon, Inc. ( ANNX ) is a clinical-stage biopharmaceutical company. The company is engaged in developing complements for patients suffering from serious complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders.", "banner_image": "https://stocknews.com/wp-content/uploads/2022/06/Biotech-Lg_FB.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Earnings", "relevance_score": "0.650727"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.955357"}], "overall_sentiment_score": 0.089368, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VRTX", "relevance_score": "0.137671", "ticker_sentiment_score": "0.041143", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.740328", "ticker_sentiment_score": "0.27022", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AMGN", "relevance_score": "0.137671", "ticker_sentiment_score": "0.041143", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIIB", "relevance_score": "0.137671", "ticker_sentiment_score": "0.041143", "ticker_sentiment_label": "Neutral"}]}, {"title": "ANNX: 4 Penny Stocks to Target Following the Latest Jobs Report", "url": "https://stocknews.com/news/annx-apre-ysg-endp-4-penny-stocks-to-target-following-the-latest-jobs-report/", "time_published": "20220714T144552", "authors": [], "summary": "U.S. inflation soared to 9.1% in June, surpassing an 8.8% estimate by Dow Jones and marking the fastest pace since November 1981. With another 75 bps federal rate hike seemingly inevitable in July, recession possibilities are rapidly growing. However, according to the U.S.", "banner_image": "https://stocknews.com/wp-content/uploads/2019/04/stock-photo-hand-putting-mix-coins-and-seed-in-clear-bottle-on-cityscape-photo-blurred-cityscape-background-298778966.jpg", "source": "Stocknews.com", "category_within_source": "n/a", "source_domain": "stocknews.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}, {"topic": "Earnings", "relevance_score": "0.998947"}], "overall_sentiment_score": 0.07727, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.280615", "ticker_sentiment_score": "0.147796", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.235366", "ticker_sentiment_score": "0.053101", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.142565", "ticker_sentiment_score": "0.186604", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENDP", "relevance_score": "0.235366", "ticker_sentiment_score": "0.082007", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner", "url": "https://www.benzinga.com/general/biotech/22/07/28031430/the-daily-biotech-pulse-gsk-to-supply-50m-flu-vaccine-doses-to-us-fda-lifts-hold-on-greenwichs-ca", "time_published": "20220712T130420", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours: GSK plc GSK has started shipping doses of its quadrivalent influenza vaccines to U.S. healthcare providers and pharmacies in preparation for the 2022-23 season, following a licensing and lot-release approval from ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/12/biotech5.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.108334, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALDX", "relevance_score": "0.115232", "ticker_sentiment_score": "0.096842", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.172097", "ticker_sentiment_score": "0.038647", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.115232", "ticker_sentiment_score": "0.165304", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ANNX", "relevance_score": "0.115232", "ticker_sentiment_score": "0.115886", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.228073", "ticker_sentiment_score": "-0.189861", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CPRX", "relevance_score": "0.115232", "ticker_sentiment_score": "-0.262147", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SQZ", "relevance_score": "0.115232", "ticker_sentiment_score": "0.215966", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APM", "relevance_score": "0.115232", "ticker_sentiment_score": "-0.111402", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSK", "relevance_score": "0.172097", "ticker_sentiment_score": "0.076079", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025", "url": "https://www.globenewswire.com/news-release/2022/07/11/2477683/0/en/Annexon-Closes-130-Million-Private-Placement-Extending-its-Operating-Runway-into-the-Second-Half-of-2025.html", "time_published": "20220711T222500", "authors": ["Annexon Biosciences"], "summary": "Proceeds Support Advancement of Broad Pipeline of Novel Complement Product Candidates for Diseases of the Body, Brain and Eye Proceeds Support Advancement of Broad Pipeline of Novel Complement Product Candidates for Diseases of the Body, Brain and Eye ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}], "overall_sentiment_score": 0.189122, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.381861", "ticker_sentiment_score": "0.305135", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025", "url": "https://www.benzinga.com/pressreleases/22/07/g28026055/annexon-closes-130-million-private-placement-extending-its-operating-runway-into-the-second-half-o", "time_published": "20220711T222500", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., July 11, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.184491, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.378181", "ticker_sentiment_score": "0.300703", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Tesla, Twitter And 76 Biggest Movers From Friday", "url": "https://www.benzinga.com/news/22/07/28014980/tesla-twitter-and-76-biggest-movers-from-friday", "time_published": "20220711T113029", "authors": ["Lisa Levin"], "summary": "Seritage Growth Properties SRG shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale. Aditxt, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/11/image_1.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.989041"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.77141"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.131149, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.085022", "ticker_sentiment_score": "0.257568", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SYRS", "relevance_score": "0.028388", "ticker_sentiment_score": "0.156634", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DRMA", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCU", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.300021", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DBD", "relevance_score": "0.085022", "ticker_sentiment_score": "0.24745", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "COIN", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "AREB", "relevance_score": "0.085022", "ticker_sentiment_score": "0.298835", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AUD", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.157966", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PHVS", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSLA", "relevance_score": "0.113195", "ticker_sentiment_score": "0.057357", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABEO", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIGA", "relevance_score": "0.056741", "ticker_sentiment_score": "0.182235", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ENJY", "relevance_score": "0.085022", "ticker_sentiment_score": "-0.030413", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.056741", "ticker_sentiment_score": "0.061833", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.056741", "ticker_sentiment_score": "0.063571", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRAX", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FSRD", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWP", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.300021", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GME", "relevance_score": "0.085022", "ticker_sentiment_score": "-0.034159", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GSUN", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.191987", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANNX", "relevance_score": "0.056741", "ticker_sentiment_score": "0.139954", "ticker_sentiment_label": "Neutral"}, {"ticker": "UXIN", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.191987", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CDLX", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.300021", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LHDX", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GMVD", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BCEL", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GLYYY", "relevance_score": "0.028388", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVO", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVK", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "APRE", "relevance_score": "0.085022", "ticker_sentiment_score": "0.118044", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPG", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MRC", "relevance_score": "0.085022", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "COCO", "relevance_score": "0.056741", "ticker_sentiment_score": "0.080226", "ticker_sentiment_label": "Neutral"}, {"ticker": "HGEN", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VJET", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFH", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "INPX", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACER", "relevance_score": "0.085022", "ticker_sentiment_score": "0.093321", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTV", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.300021", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WFC", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.149961", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.128946", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LYL", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.191987", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MARA", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDFC", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.149961", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTNP", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRUS", "relevance_score": "0.056741", "ticker_sentiment_score": "0.187985", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TWTR", "relevance_score": "0.085022", "ticker_sentiment_score": "-0.126295", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYMD", "relevance_score": "0.056741", "ticker_sentiment_score": "0.188985", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ISIG", "relevance_score": "0.056741", "ticker_sentiment_score": "0.310029", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CCO", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.142956", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRG-P-A", "relevance_score": "0.028388", "ticker_sentiment_score": "0.160513", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ELOX", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRAX", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.300021", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TH", "relevance_score": "0.056741", "ticker_sentiment_score": "0.099931", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.199991", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CFRX", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTX", "relevance_score": "0.056741", "ticker_sentiment_score": "0.245", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APPH", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CLVS", "relevance_score": "0.085022", "ticker_sentiment_score": "0.11289", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLO", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.300021", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IRTC", "relevance_score": "0.056741", "ticker_sentiment_score": "0.061927", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYME", "relevance_score": "0.085022", "ticker_sentiment_score": "0.171757", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WTRH", "relevance_score": "0.056741", "ticker_sentiment_score": "0.16397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ONVO", "relevance_score": "0.056741", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.056741", "ticker_sentiment_score": "0.271005", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UCL", "relevance_score": "0.056741", "ticker_sentiment_score": "-0.300021", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Best Penny Stocks To Buy Now? 4 To Watch After Jobs Report", "url": "https://pennystocks.com/featured/2022/07/08/best-penny-stocks-buy-now-4-watch-jobs-report/", "time_published": "20220708T143353", "authors": ["J. Samuel"], "summary": "Sometimes the best penny stocks to buy are the ones that nobody is looking at ( yet ) . The last few months of stock market trends have certainly shown that anything can happen, and even good news can make a surprising impact on stocks.", "banner_image": null, "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Economy - Monetary", "relevance_score": "0.310843"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Economy - Macro", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.02594, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.116447", "ticker_sentiment_score": "0.2473", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOOG", "relevance_score": "0.029209", "ticker_sentiment_score": "0.590956", "ticker_sentiment_label": "Bullish"}, {"ticker": "APRE", "relevance_score": "0.087472", "ticker_sentiment_score": "-0.055514", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.116447", "ticker_sentiment_score": "0.035149", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENDP", "relevance_score": "0.087472", "ticker_sentiment_score": "0.000958", "ticker_sentiment_label": "Neutral"}]}, {"title": "The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug", "url": "https://www.benzinga.com/general/biotech/22/07/27998206/the-daily-biotech-pulse-pfizer-inks-pact-with-africa-for-covid-19-pills-emergent-bio-ridgeback-to", "time_published": "20220708T121902", "authors": ["Vandana Singh"], "summary": "Here's a roundup of top developments in the biotech space over the last 24 hours: According to a Reuters report, Africa's public health body signed a memorandum of understanding with Pfizer Inc PFE, allowing African countries to access Paxlovid at cost.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/07/08/laboratory-563423_1920.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}], "overall_sentiment_score": -0.012158, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EBS", "relevance_score": "0.126985", "ticker_sentiment_score": "0.010998", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.126985", "ticker_sentiment_score": "0.001205", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.126985", "ticker_sentiment_score": "0.000447", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.189471", "ticker_sentiment_score": "0.002725", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRVB", "relevance_score": "0.126985", "ticker_sentiment_score": "0.002849", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOVF", "relevance_score": "0.126985", "ticker_sentiment_score": "0.002243", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.126985", "ticker_sentiment_score": "0.003869", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.126985", "ticker_sentiment_score": "0.010481", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVLP", "relevance_score": "0.126985", "ticker_sentiment_score": "0.001252", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Announces $130 Million Private Placement Financing", "url": "https://www.globenewswire.com/news-release/2022/07/08/2476488/0/en/Annexon-Announces-130-Million-Private-Placement-Financing.html", "time_published": "20220708T110000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., July 08, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.999763"}], "overall_sentiment_score": 0.024683, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.486054", "ticker_sentiment_score": "0.024683", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Announces $130 Million Private Placement Financing", "url": "https://www.benzinga.com/pressreleases/22/07/g27997941/annexon-announces-130-million-private-placement-financing", "time_published": "20220708T110000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., July 08, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99992"}], "overall_sentiment_score": 0.018123, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.4232", "ticker_sentiment_score": "0.026843", "ticker_sentiment_label": "Neutral"}]}, {"title": "79 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/06/27602286/79-biggest-movers-from-yesterday", "time_published": "20220608T080800", "authors": ["Lisa Levin"], "summary": "AeroClean Technologies, Inc. AERC gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company's p\u016brgo technology, classifying it as a class II medical device. Applied UV, Inc. AUVI gained 96.4% to close at $2.18. Kiromic BioPharma, Inc.", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/08/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.005964, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AGLE", "relevance_score": "0.090145", "ticker_sentiment_score": "0.004641", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTLB", "relevance_score": "0.060168", "ticker_sentiment_score": "0.007881", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVG", "relevance_score": "0.060168", "ticker_sentiment_score": "-6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.005078", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNRX", "relevance_score": "0.090145", "ticker_sentiment_score": "0.004042", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.002879", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.060168", "ticker_sentiment_score": "0.005385", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTSI", "relevance_score": "0.060168", "ticker_sentiment_score": "7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.090145", "ticker_sentiment_score": "-0.016167", "ticker_sentiment_label": "Neutral"}, {"ticker": "NINE", "relevance_score": "0.060168", "ticker_sentiment_score": "-0.000597", "ticker_sentiment_label": "Neutral"}, {"ticker": "QH", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORIC", "relevance_score": "0.060168", "ticker_sentiment_score": "0.00217", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIOX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001102", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.030105", "ticker_sentiment_score": "0.000906", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.090145", "ticker_sentiment_score": "0.00575", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.060168", "ticker_sentiment_score": "0.006867", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.060168", "ticker_sentiment_score": "0.005837", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.060168", "ticker_sentiment_score": "0.006441", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLY", "relevance_score": "0.060168", "ticker_sentiment_score": "0.003874", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001236", "ticker_sentiment_label": "Neutral"}, {"ticker": "METC", "relevance_score": "0.090145", "ticker_sentiment_score": "0.010161", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.060168", "ticker_sentiment_score": "0.141917", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLOP", "relevance_score": "0.060168", "ticker_sentiment_score": "0.006353", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.090145", "ticker_sentiment_score": "-0.001855", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.060168", "ticker_sentiment_score": "0.003021", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCTH", "relevance_score": "0.090145", "ticker_sentiment_score": "0.00818", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIFR", "relevance_score": "0.060168", "ticker_sentiment_score": "-0.002403", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.060168", "ticker_sentiment_score": "0.00156", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.090145", "ticker_sentiment_score": "-0.035409", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLOG-P-A", "relevance_score": "0.030105", "ticker_sentiment_score": "0.006353", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.002398", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCEL", "relevance_score": "0.060168", "ticker_sentiment_score": "0.005983", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001703", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.060168", "ticker_sentiment_score": "-0.000544", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.060168", "ticker_sentiment_score": "-0.000755", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.060168", "ticker_sentiment_score": "0.000254", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVFY", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001214", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.060168", "ticker_sentiment_score": "0.002622", "ticker_sentiment_label": "Neutral"}, {"ticker": "CBAY", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001529", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADTH", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001929", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.060168", "ticker_sentiment_score": "0.006886", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.060168", "ticker_sentiment_score": "0.097069", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.060168", "ticker_sentiment_score": "0.002452", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.011776", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTG", "relevance_score": "0.060168", "ticker_sentiment_score": "0.006881", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUBT", "relevance_score": "0.060168", "ticker_sentiment_score": "0.009393", "ticker_sentiment_label": "Neutral"}, {"ticker": "PMVP", "relevance_score": "0.090145", "ticker_sentiment_score": "0.001836", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.060168", "ticker_sentiment_score": "0.007711", "ticker_sentiment_label": "Neutral"}, {"ticker": "DHX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.000325", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.060168", "ticker_sentiment_score": "0.008086", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRBP", "relevance_score": "0.060168", "ticker_sentiment_score": "0.012776", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSIX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.114308", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNCE", "relevance_score": "0.090145", "ticker_sentiment_score": "0.00607", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMMB", "relevance_score": "0.060168", "ticker_sentiment_score": "0.005792", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.090145", "ticker_sentiment_score": "0.001129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.060168", "ticker_sentiment_score": "0.029703", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001979", "ticker_sentiment_label": "Neutral"}, {"ticker": "URGN", "relevance_score": "0.060168", "ticker_sentiment_score": "0.000408", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.090145", "ticker_sentiment_score": "0.006744", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001586", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSGM", "relevance_score": "0.060168", "ticker_sentiment_score": "0.005624", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.060168", "ticker_sentiment_score": "0.002325", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGAP", "relevance_score": "0.030105", "ticker_sentiment_score": "0.013429", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSS", "relevance_score": "0.060168", "ticker_sentiment_score": "0.013429", "ticker_sentiment_label": "Neutral"}, {"ticker": "INKT", "relevance_score": "0.060168", "ticker_sentiment_score": "0.002686", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUYA", "relevance_score": "0.060168", "ticker_sentiment_score": "0.007685", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANTX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.004269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPSI", "relevance_score": "0.090145", "ticker_sentiment_score": "0.114308", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRKA", "relevance_score": "0.090145", "ticker_sentiment_score": "0.002253", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.003539", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRC", "relevance_score": "0.060168", "ticker_sentiment_score": "-0.00086", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAN", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001129", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.060168", "ticker_sentiment_score": "0.000595", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.060168", "ticker_sentiment_score": "0.024628", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIII", "relevance_score": "0.060168", "ticker_sentiment_score": "0.00176", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.060168", "ticker_sentiment_score": "-0.003002", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.060168", "ticker_sentiment_score": "0.001095", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.060168", "ticker_sentiment_score": "0.006483", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Touts Final Huntington's Trial Data Confirming No New Safety Issues", "url": "https://www.benzinga.com/general/biotech/22/06/27591329/annexon-touts-final-huntingtons-trial-data-confirming-no-new-safety-issues", "time_published": "20220607T161903", "authors": ["Vandana Singh"], "summary": "Annexon Inc ( NASDAQ: ANNX ) shared final data from the Phase 2 trial for ANX005 in patients with or at risk for Huntington's disease, which causes a progressive breakdown of nerve cells in the brain. The 28 patients were dosed for six months and followed for three more. The goal of the study was", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/06/07/aapharma_5.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": -0.044982, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.547593", "ticker_sentiment_score": "0.009164", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences Reports Phase 2 Clinical Trial Results Demonstrating Upstream Classical Complement Inhibition Associated with Clinical Benefit in Huntington's Disease", "url": "https://www.globenewswire.com/news-release/2022/06/07/2457463/0/en/Annexon-Biosciences-Reports-Phase-2-Clinical-Trial-Results-Demonstrating-Upstream-Classical-Complement-Inhibition-Associated-with-Clinical-Benefit-in-Huntington-s-Disease.html", "time_published": "20220607T103000", "authors": ["Annexon Biosciences"], "summary": "ANX005 Demonstrated Full C1q Target Inhibition and Was Generally Well-Tolerated", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.104161, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.189076", "ticker_sentiment_score": "0.213885", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Annexon Biosciences to Present at the 2022 Jefferies Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/06/02/2454978/0/en/Annexon-Biosciences-to-Present-at-the-2022-Jefferies-Healthcare-Conference.html", "time_published": "20220602T103000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., June 02, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announce", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.059198, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.820913", "ticker_sentiment_score": "0.059198", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Present at the 2022 Jefferies Healthcare Conference", "url": "https://www.benzinga.com/pressreleases/22/06/g27517261/annexon-biosciences-to-present-at-the-2022-jefferies-healthcare-conference", "time_published": "20220602T103000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., June 02, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( NASDAQ:ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.041205, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.725852", "ticker_sentiment_score": "0.062903", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Present Data Highlighting Novel Approach to Treating Complement-Driven Diseases at Upcoming Medical Meetings", "url": "https://www.globenewswire.com/news-release/2022/06/01/2454125/0/en/Annexon-Biosciences-to-Present-Data-Highlighting-Novel-Approach-to-Treating-Complement-Driven-Diseases-at-Upcoming-Medical-Meetings.html", "time_published": "20220601T113000", "authors": ["Annexon Biosciences"], "summary": "BRISBANE, Calif., June 01, 2022 ( GLOBE NEWSWIRE ) -- Annexon, Inc. ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announce", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": 0.033362, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.323184", "ticker_sentiment_score": "0.079376", "ticker_sentiment_label": "Neutral"}]}, {"title": "103 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/05/27130447/103-biggest-movers-from-yesterday", "time_published": "20220511T102237", "authors": ["Lisa Levin"], "summary": "Gainers\nBiohaven Pharmaceutical Holding Company Ltd.   ( NASDAQ: BHVN )  shares surged 68.4% to close at $140.00 on Tuesday. Pfizer Inc  ( NYSE: PFE )  will acquire Biohaven Pharmaceutical Holding for $148.50 per share, equivalent to $11.6 billion.\nBaosheng Media Group Holdings Limited  ( NASDAQ: BA", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/05/11/yesterdays_movers.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.034609, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VGFC", "relevance_score": "0.042685", "ticker_sentiment_score": "0.664321", "ticker_sentiment_label": "Bullish"}, {"ticker": "STG", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.008567", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPN", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.515328", "ticker_sentiment_label": "Bearish"}, {"ticker": "MTRX", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.070559", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGEN", "relevance_score": "0.042685", "ticker_sentiment_score": "0.081143", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEAM", "relevance_score": "0.042685", "ticker_sentiment_score": "0.002025", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARG", "relevance_score": "0.042685", "ticker_sentiment_score": "0.00299", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.042685", "ticker_sentiment_score": "0.003708", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCL", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.004857", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYE", "relevance_score": "0.042685", "ticker_sentiment_score": "0.00027", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.194944", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VRM", "relevance_score": "0.042685", "ticker_sentiment_score": "0.019302", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARA", "relevance_score": "0.042685", "ticker_sentiment_score": "0.020877", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.06399", "ticker_sentiment_score": "0.000177", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMAB", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.046154", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.042685", "ticker_sentiment_score": "0.005781", "ticker_sentiment_label": "Neutral"}, {"ticker": "MICT", "relevance_score": "0.042685", "ticker_sentiment_score": "0.022064", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.06399", "ticker_sentiment_score": "0.066074", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNT", "relevance_score": "0.042685", "ticker_sentiment_score": "0.125608", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKOH", "relevance_score": "0.042685", "ticker_sentiment_score": "0.066193", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUPH", "relevance_score": "0.042685", "ticker_sentiment_score": "0.018098", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOV", "relevance_score": "0.042685", "ticker_sentiment_score": "0.01036", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.004606", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATER", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.523031", "ticker_sentiment_label": "Bearish"}, {"ticker": "CVT", "relevance_score": "0.042685", "ticker_sentiment_score": "0.000467", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.042685", "ticker_sentiment_score": "0.004676", "ticker_sentiment_label": "Neutral"}, {"ticker": "DPSIP", "relevance_score": "0.02135", "ticker_sentiment_score": "0.000792", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.042685", "ticker_sentiment_score": "0.001143", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYX", "relevance_score": "0.06399", "ticker_sentiment_score": "-0.09562", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.02135", "ticker_sentiment_score": "0.035797", "ticker_sentiment_label": "Neutral"}, {"ticker": "BW", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.083184", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIGI", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.016543", "ticker_sentiment_label": "Neutral"}, {"ticker": "CECE", "relevance_score": "0.042685", "ticker_sentiment_score": "0.051752", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHVN", "relevance_score": "0.06399", "ticker_sentiment_score": "0.003708", "ticker_sentiment_label": "Neutral"}, {"ticker": "LWLG", "relevance_score": "0.042685", "ticker_sentiment_score": "0.001157", "ticker_sentiment_label": "Neutral"}, {"ticker": "JCSE", "relevance_score": "0.042685", "ticker_sentiment_score": "0.001316", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAE", "relevance_score": "0.042685", "ticker_sentiment_score": "0.04042", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.007721", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPN", "relevance_score": "0.085249", "ticker_sentiment_score": "-0.0287", "ticker_sentiment_label": "Neutral"}, {"ticker": "VECO", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.031876", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELU", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.008233", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPF", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.135042", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.042685", "ticker_sentiment_score": "0.002497", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.06399", "ticker_sentiment_score": "-0.066617", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.042685", "ticker_sentiment_score": "0.036447", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTP", "relevance_score": "0.042685", "ticker_sentiment_score": "0.000305", "ticker_sentiment_label": "Neutral"}, {"ticker": "DM", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.035549", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPK", "relevance_score": "0.042685", "ticker_sentiment_score": "0.003853", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRON", "relevance_score": "0.042685", "ticker_sentiment_score": "0.003106", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMST", "relevance_score": "0.042685", "ticker_sentiment_score": "0.019641", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCI", "relevance_score": "0.042685", "ticker_sentiment_score": "0.00765", "ticker_sentiment_label": "Neutral"}, {"ticker": "VFF", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.103262", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.042685", "ticker_sentiment_score": "0.096046", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.042685", "ticker_sentiment_score": "0.002996", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRAX", "relevance_score": "0.06399", "ticker_sentiment_score": "0.022847", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.042685", "ticker_sentiment_score": "0.013968", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEA", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.077706", "ticker_sentiment_label": "Neutral"}, {"ticker": "UIHC", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.551759", "ticker_sentiment_label": "Bearish"}, {"ticker": "ANNX", "relevance_score": "0.06399", "ticker_sentiment_score": "-0.035967", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRUE", "relevance_score": "0.06399", "ticker_sentiment_score": "-0.049112", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.085249", "ticker_sentiment_score": "-0.0287", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIFR", "relevance_score": "0.06399", "ticker_sentiment_score": "-0.008168", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.042685", "ticker_sentiment_score": "0.009946", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.06399", "ticker_sentiment_score": "-0.010703", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIL", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.075598", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.042685", "ticker_sentiment_score": "0.001916", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.042685", "ticker_sentiment_score": "0.008086", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.023714", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHC", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.033879", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOGC", "relevance_score": "0.06399", "ticker_sentiment_score": "0.014214", "ticker_sentiment_label": "Neutral"}, {"ticker": "CENN", "relevance_score": "0.042685", "ticker_sentiment_score": "0.035797", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWAV", "relevance_score": "0.042685", "ticker_sentiment_score": "0.035201", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGS", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.669791", "ticker_sentiment_label": "Bearish"}, {"ticker": "FF", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.016612", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDRX", "relevance_score": "0.042685", "ticker_sentiment_score": "0.000704", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFI", "relevance_score": "0.042685", "ticker_sentiment_score": "8.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.003523", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMNA", "relevance_score": "0.02135", "ticker_sentiment_score": "0.022064", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHCO", "relevance_score": "0.042685", "ticker_sentiment_score": "0.028044", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.124904", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.042685", "ticker_sentiment_score": "0.012588", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMBK", "relevance_score": "0.042685", "ticker_sentiment_score": "0.005832", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNTG", "relevance_score": "0.042685", "ticker_sentiment_score": "0.090001", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRT", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.003171", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRBP", "relevance_score": "0.042685", "ticker_sentiment_score": "0.000277", "ticker_sentiment_label": "Neutral"}, {"ticker": "GB", "relevance_score": "0.042685", "ticker_sentiment_score": "0.005013", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGEN", "relevance_score": "0.06399", "ticker_sentiment_score": "0.011826", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNCE", "relevance_score": "0.06399", "ticker_sentiment_score": "0.05527", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASRT", "relevance_score": "0.042685", "ticker_sentiment_score": "0.047574", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRA", "relevance_score": "0.06399", "ticker_sentiment_score": "0.002747", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAVE", "relevance_score": "0.042685", "ticker_sentiment_score": "0.001764", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITCI", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.005046", "ticker_sentiment_label": "Neutral"}, {"ticker": "BHIL", "relevance_score": "0.042685", "ticker_sentiment_score": "0.001122", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.042685", "ticker_sentiment_score": "0.003322", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLG", "relevance_score": "0.042685", "ticker_sentiment_score": "-0.012307", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.042685", "ticker_sentiment_score": "0.00259", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPSN", "relevance_score": "0.042685", "ticker_sentiment_score": "0.001049", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNON", "relevance_score": "0.042685", "ticker_sentiment_score": "5.2e-05", "ticker_sentiment_label": "Neutral"}]}, {"title": "ADCT Awaits Cami Trial Data, CSTL Boosts Revenue Outlook, ANNX To Report HD Trial Data In Q2", "url": "https://markets.businessinsider.com/news/stocks/adct-awaits-cami-trial-data-cstl-boosts-revenue-outlook-annx-to-report-hd-trial-data-in-q2-1031440845", "time_published": "20220510T094515", "authors": [], "summary": "( RTTNews )  - The following are some of the companies belonging to the healthcare sector that reported quarterly earnings and provided an update on their pipeline progress on Monday.", "banner_image": "https://markets.businessinsider.com/Images/FacebookIcon.jpg", "source": "Business Insider", "category_within_source": "n/a", "source_domain": "markets.businessinsider.com", "topics": [{"topic": "Earnings", "relevance_score": "1.0"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.040576, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FOLD", "relevance_score": "0.065452", "ticker_sentiment_score": "0.167337", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CARA", "relevance_score": "0.065452", "ticker_sentiment_score": "0.164496", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CSTL", "relevance_score": "0.065452", "ticker_sentiment_score": "0.083871", "ticker_sentiment_label": "Neutral"}, {"ticker": "EGRX", "relevance_score": "0.065452", "ticker_sentiment_score": "0.359735", "ticker_sentiment_label": "Bullish"}, {"ticker": "ANNX", "relevance_score": "0.065452", "ticker_sentiment_score": "0.125946", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.098041", "ticker_sentiment_score": "0.010487", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESTA", "relevance_score": "0.065452", "ticker_sentiment_score": "0.015493", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.065452", "ticker_sentiment_score": "0.000385", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.065452", "ticker_sentiment_score": "0.022633", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIFE", "relevance_score": "0.065452", "ticker_sentiment_score": "0.002373", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Participate in Upcoming May Investor Conferences", "url": "https://www.benzinga.com/pressreleases/22/05/g27013929/annexon-biosciences-to-participate-in-upcoming-may-investor-conferences", "time_published": "20220505T103000", "authors": ["Globe Newswire"], "summary": "BRISBANE, Calif., May  05, 2022   ( GLOBE NEWSWIRE )  -- Annexon, Inc.  ( NASDAQ:ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced ", "banner_image": "https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.029992, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.633388", "ticker_sentiment_score": "0.050372", "ticker_sentiment_label": "Neutral"}]}, {"title": "53 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/04/26731039/53-biggest-movers-from-yesterday", "time_published": "20220421T085205", "authors": [], "summary": "Gainers\nION Geophysical Corporation  ( NYSE: IO )  shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum Co. for a digital solution to manage Marine Logistics.\nWinc, Inc.  ( NYSE: WBEV )  shares jumped 65.1% to close at $5.0", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/21/yesterdays_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.962106"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": 0.001493, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "LRN", "relevance_score": "0.103094", "ticker_sentiment_score": "0.007389", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLAP", "relevance_score": "0.103094", "ticker_sentiment_score": "0.004504", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001444", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001072", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000736", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANEB", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000892", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTCO", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001194", "ticker_sentiment_label": "Neutral"}, {"ticker": "HNRG", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000947", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEXX", "relevance_score": "0.103094", "ticker_sentiment_score": "0.001378", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.068836", "ticker_sentiment_score": "-0.021776", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGHL", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000786", "ticker_sentiment_label": "Neutral"}, {"ticker": "REDU", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001058", "ticker_sentiment_label": "Neutral"}, {"ticker": "METC", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000823", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.103094", "ticker_sentiment_score": "0.00669", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.03445", "ticker_sentiment_score": "-0.008963", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.103094", "ticker_sentiment_score": "0.008042", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000828", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCORF", "relevance_score": "0.03445", "ticker_sentiment_score": "0.013515", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.068836", "ticker_sentiment_score": "-0.000367", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.068836", "ticker_sentiment_score": "0.00594", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDBX", "relevance_score": "0.103094", "ticker_sentiment_score": "0.013515", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000339", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLLY", "relevance_score": "0.103094", "ticker_sentiment_score": "0.001492", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.03445", "ticker_sentiment_score": "0.006629", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASA", "relevance_score": "0.103094", "ticker_sentiment_score": "0.005734", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEEM", "relevance_score": "0.068836", "ticker_sentiment_score": "0.002639", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.068836", "ticker_sentiment_score": "0.01362", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMEX", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000685", "ticker_sentiment_label": "Neutral"}, {"ticker": "CAR", "relevance_score": "0.068836", "ticker_sentiment_score": "0.006629", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.068836", "ticker_sentiment_score": "0.004876", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.068836", "ticker_sentiment_score": "0.002678", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATER", "relevance_score": "0.068836", "ticker_sentiment_score": "-0.018264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.068836", "ticker_sentiment_score": "-0.004568", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.03445", "ticker_sentiment_score": "0.005734", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.03445", "ticker_sentiment_score": "0.01362", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHRA", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001063", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGVN", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001649", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.068836", "ticker_sentiment_score": "-0.000343", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTS", "relevance_score": "0.068836", "ticker_sentiment_score": "0.002417", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.103094", "ticker_sentiment_score": "0.025623", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.103094", "ticker_sentiment_score": "-0.008963", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSSE", "relevance_score": "0.068836", "ticker_sentiment_score": "0.019503", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.137161", "ticker_sentiment_score": "-0.008634", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTP", "relevance_score": "0.103094", "ticker_sentiment_score": "0.017839", "ticker_sentiment_label": "Neutral"}, {"ticker": "WATT", "relevance_score": "0.103094", "ticker_sentiment_score": "0.012534", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.068836", "ticker_sentiment_score": "0.00022", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAB", "relevance_score": "0.103094", "ticker_sentiment_score": "0.008336", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.03445", "ticker_sentiment_score": "-0.021776", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.068836", "ticker_sentiment_score": "0.002131", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELZ", "relevance_score": "0.103094", "ticker_sentiment_score": "0.080156", "ticker_sentiment_label": "Neutral"}, {"ticker": "GWGH", "relevance_score": "0.103094", "ticker_sentiment_score": "0.001105", "ticker_sentiment_label": "Neutral"}, {"ticker": "TH", "relevance_score": "0.068836", "ticker_sentiment_score": "0.002929", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATXI", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001846", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEL", "relevance_score": "0.068836", "ticker_sentiment_score": "0.001696", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.068836", "ticker_sentiment_score": "0.000736", "ticker_sentiment_label": "Neutral"}]}, {"title": "What Are Penny Stocks? What You Need to Know and 3 to Watch", "url": "https://pennystocks.com/featured/2022/04/20/what-are-penny-stocks-what-need-know-3-watch/", "time_published": "20220420T194134", "authors": [], "summary": "Check these three penny stocks out for your watchlist\nThe post What Are Penny Stocks? What You Need to Know and 3 to Watch  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.", "banner_image": "https://pennystocks.com/wp-content/uploads/2022/04/Penny_Stocks_to_Watch_Petros-Pharmaceuticals-PTPI-Stock-Chart.jpg", "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Energy & Transportation", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.182378, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "WINT", "relevance_score": "0.08589", "ticker_sentiment_score": "0.082304", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.128523", "ticker_sentiment_score": "0.125917", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.08589", "ticker_sentiment_score": "0.082304", "ticker_sentiment_label": "Neutral"}]}, {"title": "54 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/04/26706319/54-biggest-movers-from-yesterday", "time_published": "20220420T094334", "authors": [], "summary": "Gainers\nCheckmate Pharmaceuticals, Inc.  ( NASDAQ: CMPI )  shares jumped 325.9% to close at $10.35 on Tuesday after Regeneron Pharmaceuticals, Inc.  ( NASDAQ: REGN )  announced a deal to acquire the company for $10.50 per share in cash.\nSono Group N.V.  ( NASDAQ: SEV )  climbed 65.2% to close at $7.", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/20/yesterdays_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.001994, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ZEN", "relevance_score": "0.069124", "ticker_sentiment_score": "0.018984", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCDA", "relevance_score": "0.069124", "ticker_sentiment_score": "0.00044", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLAP", "relevance_score": "0.069124", "ticker_sentiment_score": "0.001686", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000353", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRGE", "relevance_score": "0.069124", "ticker_sentiment_score": "0.003068", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.069124", "ticker_sentiment_score": "0.00815", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000207", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.034595", "ticker_sentiment_score": "-0.001069", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.069124", "ticker_sentiment_score": "4e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGHL", "relevance_score": "0.069124", "ticker_sentiment_score": "-0.000393", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTY", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000523", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.069124", "ticker_sentiment_score": "0.005871", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.103524", "ticker_sentiment_score": "0.001286", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNTG", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000668", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.103524", "ticker_sentiment_score": "0.00183", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.069124", "ticker_sentiment_score": "0.003104", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTX", "relevance_score": "0.069124", "ticker_sentiment_score": "0.005263", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.069124", "ticker_sentiment_score": "0.001426", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000368", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.034595", "ticker_sentiment_score": "0.017405", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASA", "relevance_score": "0.103524", "ticker_sentiment_score": "0.018997", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.103524", "ticker_sentiment_score": "0.002007", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.069124", "ticker_sentiment_score": "0.002101", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.103524", "ticker_sentiment_score": "-0.052458", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.069124", "ticker_sentiment_score": "0.018997", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.069124", "ticker_sentiment_score": "0.002007", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEV", "relevance_score": "0.069124", "ticker_sentiment_score": "0.001593", "ticker_sentiment_label": "Neutral"}, {"ticker": "JP", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000318", "ticker_sentiment_label": "Neutral"}, {"ticker": "WE", "relevance_score": "0.034595", "ticker_sentiment_score": "0.014621", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXSM", "relevance_score": "0.069124", "ticker_sentiment_score": "0.004167", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLT", "relevance_score": "0.069124", "ticker_sentiment_score": "-0.094647", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTPI", "relevance_score": "0.069124", "ticker_sentiment_score": "0.005332", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIGI", "relevance_score": "0.103524", "ticker_sentiment_score": "-0.000106", "ticker_sentiment_label": "Neutral"}, {"ticker": "CISO", "relevance_score": "0.069124", "ticker_sentiment_score": "-0.005525", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNG", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000954", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYRA", "relevance_score": "0.103524", "ticker_sentiment_score": "-0.001104", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000366", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACC", "relevance_score": "0.069124", "ticker_sentiment_score": "0.004426", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.069124", "ticker_sentiment_score": "0.021599", "ticker_sentiment_label": "Neutral"}, {"ticker": "USEG", "relevance_score": "0.069124", "ticker_sentiment_score": "0.000727", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.069124", "ticker_sentiment_score": "0.003532", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.103524", "ticker_sentiment_score": "0.004562", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.069124", "ticker_sentiment_score": "0.001271", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.069124", "ticker_sentiment_score": "0.049341", "ticker_sentiment_label": "Neutral"}, {"ticker": "SST", "relevance_score": "0.069124", "ticker_sentiment_score": "-0.000168", "ticker_sentiment_label": "Neutral"}, {"ticker": "CADL", "relevance_score": "0.069124", "ticker_sentiment_score": "0.006355", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPI", "relevance_score": "0.069124", "ticker_sentiment_score": "0.00438", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.069124", "ticker_sentiment_score": "0.00438", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.069124", "ticker_sentiment_score": "0.001719", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.034595", "ticker_sentiment_score": "-0.000106", "ticker_sentiment_label": "Neutral"}]}, {"title": "38 Stocks Moving In Tuesday's Mid-Day Session", "url": "https://www.benzinga.com/news/22/04/26694580/38-stocks-moving-in-tuesdays-mid-day-session", "time_published": "20220419T161631", "authors": [], "summary": "Gainers\nCheckmate Pharmaceuticals, Inc.  ( NASDAQ: CMPI )  climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc.  ( NASDAQ: REGN )  announced a deal to acquire the company for $10.50 per share in cash.\nToughBuilt Industries, Inc.   ( NASDAQ: TBLT )  jumped 72.2% to $0.2526 as the company po", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/mid-day_movers_image_0.jpg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.006624, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIDU", "relevance_score": "0.15119", "ticker_sentiment_score": "-0.087822", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEN", "relevance_score": "0.101132", "ticker_sentiment_score": "0.010858", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.101132", "ticker_sentiment_score": "0.014599", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEV", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000426", "ticker_sentiment_label": "Neutral"}, {"ticker": "WE", "relevance_score": "0.050668", "ticker_sentiment_score": "0.01046", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.101132", "ticker_sentiment_score": "5.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXSM", "relevance_score": "0.101132", "ticker_sentiment_score": "0.002669", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLT", "relevance_score": "0.101132", "ticker_sentiment_score": "-0.062005", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.101132", "ticker_sentiment_score": "0.00061", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFFN", "relevance_score": "0.101132", "ticker_sentiment_score": "-0.000908", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRGV", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000842", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.050668", "ticker_sentiment_score": "-0.000444", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIGI", "relevance_score": "0.15119", "ticker_sentiment_score": "-0.001525", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.101132", "ticker_sentiment_score": "-0.000754", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNG", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000155", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000134", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACC", "relevance_score": "0.101132", "ticker_sentiment_score": "0.004546", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTY", "relevance_score": "0.101132", "ticker_sentiment_score": "0.00067", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.101132", "ticker_sentiment_score": "0.00437", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000894", "ticker_sentiment_label": "Neutral"}, {"ticker": "USEG", "relevance_score": "0.101132", "ticker_sentiment_score": "-0.000134", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNTG", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000305", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.15119", "ticker_sentiment_score": "0.00042", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000318", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRN", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRCC", "relevance_score": "0.101132", "ticker_sentiment_score": "-0.000331", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000199", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.050668", "ticker_sentiment_score": "0.022725", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASA", "relevance_score": "0.15119", "ticker_sentiment_score": "0.014599", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.101132", "ticker_sentiment_score": "0.046493", "ticker_sentiment_label": "Neutral"}, {"ticker": "SST", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000218", "ticker_sentiment_label": "Neutral"}, {"ticker": "CADL", "relevance_score": "0.101132", "ticker_sentiment_score": "0.000883", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMPI", "relevance_score": "0.101132", "ticker_sentiment_score": "0.004093", "ticker_sentiment_label": "Neutral"}, {"ticker": "REGN", "relevance_score": "0.101132", "ticker_sentiment_score": "0.004093", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTC", "relevance_score": "0.050668", "ticker_sentiment_score": "-0.001525", "ticker_sentiment_label": "Neutral"}]}, {"title": "23 Stocks Moving in Tuesday's Pre-Market Session", "url": "https://www.benzinga.com/news/22/04/26682742/23-stocks-moving-in-tuesdays-pre-market-session", "time_published": "20220419T103745", "authors": [], "summary": "Gainers\nToughBuilt Industries, Inc.   ( NASDAQ: TBLT )  rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss.\nSharps Technology, Inc.  ( NASDAQ: STSS )  shares rose 38.4% to $2.92 in pre-market trading after dipping 18% on Monday. The company recently priced its IPO", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/premkt_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.910869"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Energy & Transportation", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}], "overall_sentiment_score": -0.037242, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "SIDU", "relevance_score": "0.190117", "ticker_sentiment_score": "-0.063452", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEN", "relevance_score": "0.190117", "ticker_sentiment_score": "0.004154", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFET", "relevance_score": "0.190117", "ticker_sentiment_score": "0.000845", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.127422", "ticker_sentiment_score": "0.008478", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPSN", "relevance_score": "0.127422", "ticker_sentiment_score": "0.002476", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMCI", "relevance_score": "0.127422", "ticker_sentiment_score": "0.003857", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.127422", "ticker_sentiment_score": "0.001666", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.127422", "ticker_sentiment_score": "0.000244", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNTG", "relevance_score": "0.127422", "ticker_sentiment_score": "0.000361", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.190117", "ticker_sentiment_score": "0.000243", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.127422", "ticker_sentiment_score": "0.001319", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOGL", "relevance_score": "0.127422", "ticker_sentiment_score": "6.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTT", "relevance_score": "0.127422", "ticker_sentiment_score": "0.000263", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMRA", "relevance_score": "0.190117", "ticker_sentiment_score": "-0.351467", "ticker_sentiment_label": "Bearish"}, {"ticker": "TBLT", "relevance_score": "0.127422", "ticker_sentiment_score": "-0.016348", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASA", "relevance_score": "0.190117", "ticker_sentiment_score": "0.008478", "ticker_sentiment_label": "Neutral"}, {"ticker": "SST", "relevance_score": "0.127422", "ticker_sentiment_score": "0.000116", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACAD", "relevance_score": "0.127422", "ticker_sentiment_score": "-0.007302", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNG", "relevance_score": "0.127422", "ticker_sentiment_score": "2.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.127422", "ticker_sentiment_score": "-0.000277", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/04/26669813/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220418T154044", "authors": [], "summary": "On Monday, 466 companies hit new 52-week lows.\nNoteworthy Highlights From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Walt Disney  ( NYSE:DIS ) .\nThe smallest company on a market cap basis to set a new 52-week low was InVivo Therapeutics Hldg  ( NASDAQ:NVIV )", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_6728.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.017864, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VIAV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002621", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003856", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.213067", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SESN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000595", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.293142", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ACCO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007652", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012013", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.023223", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010655", "ticker_sentiment_label": "Neutral"}, {"ticker": "STT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.022953", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.005428", "ticker_sentiment_score": "-4.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00106", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALEC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012709", "ticker_sentiment_label": "Neutral"}, {"ticker": "FARO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001331", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.272565", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BTCM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002319", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.005428", "ticker_sentiment_score": "0.015021", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.021725", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011478", "ticker_sentiment_label": "Neutral"}, {"ticker": "NODK", "relevance_score": "0.005428", "ticker_sentiment_score": "1.1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000121", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.011872", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006403", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013529", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAV", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002946", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002512", "ticker_sentiment_label": "Neutral"}, {"ticker": "METX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00156", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001026", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008567", "ticker_sentiment_label": "Neutral"}, {"ticker": "CERS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006455", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWVL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000145", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNEY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.393211", "ticker_sentiment_label": "Bearish"}, {"ticker": "NDRA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001256", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.168617", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALGS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000859", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.072563", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002619", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003807", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000646", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALTG-P-A", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000193", "ticker_sentiment_label": "Neutral"}, {"ticker": "BQ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000507", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRY", "relevance_score": "0.005428", "ticker_sentiment_score": "0.024824", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKSI", "relevance_score": "0.005428", "ticker_sentiment_score": "-8.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005213", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000999", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWH", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001442", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRBK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000264", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.019851", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005448", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001483", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00029", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.148476", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031319", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGRU", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001445", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.005428", "ticker_sentiment_score": "5.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.005428", "ticker_sentiment_score": "0.034663", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001707", "ticker_sentiment_label": "Neutral"}, {"ticker": "INST", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000759", "ticker_sentiment_label": "Neutral"}, {"ticker": "COHU", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000175", "ticker_sentiment_label": "Neutral"}, {"ticker": "KWR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000293", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003698", "ticker_sentiment_label": "Neutral"}, {"ticker": "LII", "relevance_score": "0.005428", "ticker_sentiment_score": "0.019272", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012305", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005128", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIS", "relevance_score": "0.010855", "ticker_sentiment_score": "0.013698", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.021159", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.029413", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPGP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001813", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014272", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011583", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.010204", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001225", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.014752", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014443", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001214", "ticker_sentiment_label": "Neutral"}, {"ticker": "REV", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.300391", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ETNB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.218213", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZNTL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000217", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.035983", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002199", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002407", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.007737", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031658", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.02329", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.052558", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012134", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011935", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005133", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.00035", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBCI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005416", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTLO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010832", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001718", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.009318", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013213", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002222", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002273", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00501", "ticker_sentiment_label": "Neutral"}, {"ticker": "VVNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012228", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014175", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNEJF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005016", "ticker_sentiment_label": "Neutral"}, {"ticker": "SANW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00084", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00258", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACHL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00077", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.201905", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.018219", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.013285", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBIO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007266", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004162", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.022314", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVR", "relevance_score": "0.005428", "ticker_sentiment_score": "6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001694", "ticker_sentiment_label": "Neutral"}, {"ticker": "FDMT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00084", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004346", "ticker_sentiment_label": "Neutral"}, {"ticker": "MASI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000535", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALKT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000246", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.0434", "ticker_sentiment_score": "-0.032182", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014396", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVIV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005773", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010281", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002196", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFFN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012272", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001501", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.010843", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.010855", "ticker_sentiment_score": "-0.016624", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004914", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMCL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005187", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORMP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004864", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009875", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000128", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003774", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSTL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003205", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.218246", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OTRK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000812", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFTR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009878", "ticker_sentiment_label": "Neutral"}, {"ticker": "CARR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001383", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTRS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.021764", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003243", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.024154", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.010855", "ticker_sentiment_score": "-0.003513", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000456", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002645", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00915", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001791", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.012632", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001613", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSKEF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006448", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013727", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004002", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.020798", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011236", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002607", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001081", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003031", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002874", "ticker_sentiment_label": "Neutral"}, {"ticker": "MATW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014647", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.025859", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.005691", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.031145", "ticker_sentiment_label": "Neutral"}, {"ticker": "IBRX", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005207", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.005428", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYME", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001234", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00633", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "XGN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.034691", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.005096", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.075873", "ticker_sentiment_score": "-0.020157", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMAT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.422547", "ticker_sentiment_label": "Bearish"}, {"ticker": "IDYA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000207", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.014477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.012332", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000505", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000697", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004763", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.21154", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SKYT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002215", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003718", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.011845", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001918", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003493", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001372", "ticker_sentiment_label": "Neutral"}, {"ticker": "BPTH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.216618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "INMD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.028707", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002589", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAVA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISUN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.016146", "ticker_sentiment_label": "Neutral"}, {"ticker": "SITE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007096", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003183", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXPL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008084", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUV", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001675", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.005428", "ticker_sentiment_score": "0.006956", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.00195", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMBIL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000167", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.026958", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000638", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001126", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.010855", "ticker_sentiment_score": "0.182297", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GGR", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002554", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.029415", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000584", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003726", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLBY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000855", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003329", "ticker_sentiment_label": "Neutral"}, {"ticker": "CREX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003361", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.016527", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.009244", "ticker_sentiment_label": "Neutral"}, {"ticker": "ORTX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.011111", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001247", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUCD", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013516", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLCN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000703", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.24229", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APYX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.003348", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.017793", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000686", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIKI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.001314", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001623", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMK", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013866", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.026143", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.015312", "ticker_sentiment_label": "Neutral"}, {"ticker": "YELL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.019485", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.025877", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.005428", "ticker_sentiment_score": "3.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004797", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006973", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012472", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNSO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.272945", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FAMI", "relevance_score": "0.005428", "ticker_sentiment_score": "0.013901", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGEN", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.004544", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.005428", "ticker_sentiment_score": "0.002467", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRC", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.008006", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFUS", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000546", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00496", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000815", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.005428", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.017485", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.022374", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00834", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.054091", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.005428", "ticker_sentiment_score": "0.006165", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.005428", "ticker_sentiment_score": "-6e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.017634", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.005428", "ticker_sentiment_score": "0.001634", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000368", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.006809", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003146", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.067704", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.005428", "ticker_sentiment_score": "0.02", "ticker_sentiment_label": "Neutral"}, {"ticker": "DELL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00953", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.013699", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTP", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00091", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000528", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000163", "ticker_sentiment_label": "Neutral"}, {"ticker": "AAOI", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.009025", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.003913", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.002153", "ticker_sentiment_label": "Neutral"}, {"ticker": "YORW", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.0031", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.005428", "ticker_sentiment_score": "0.004918", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000963", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.007987", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLRE", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.00352", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEL", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.156421", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RUBY", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.000733", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.005428", "ticker_sentiment_score": "-0.012305", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/news/22/04/26547302/stocks-that-hit-52-week-lows-on-friday", "time_published": "20220408T163534", "authors": [], "summary": "During Friday's morning session, 234 stocks hit new 52-week lows.\nInteresting Facts About Today's 52-Week Lows:\nThe largest company in terms of market cap to set a new 52-week low was U.S. Bancorp  ( NYSE:USB ) .\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest company in terms of market ca", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_6187.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Economy - Monetary", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.009678, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.011399", "ticker_sentiment_score": "0.001149", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSNT", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.259368", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GRPH", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.022774", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEX", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.026292", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSBF", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.022219", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.01035", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000998", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.034188", "ticker_sentiment_score": "0.001727", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENFN", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.001932", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLMA", "relevance_score": "0.011399", "ticker_sentiment_score": "0.0043", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.010673", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005005", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.00889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.011399", "ticker_sentiment_score": "3e-06", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.011399", "ticker_sentiment_score": "0.00652", "ticker_sentiment_label": "Neutral"}, {"ticker": "DENN", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.006381", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.000557", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.003948", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTHR", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.000721", "ticker_sentiment_label": "Neutral"}, {"ticker": "GEG", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.037942", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.004497", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002161", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.004553", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCMI", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005146", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.274161", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GHLD", "relevance_score": "0.011399", "ticker_sentiment_score": "0.001119", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.00251", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTE", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.243275", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SWVL", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.001883", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.011399", "ticker_sentiment_score": "0.046331", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.019105", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.169692", "ticker_sentiment_score": "0.020365", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.010039", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.039526", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.010111", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000241", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.003727", "ticker_sentiment_label": "Neutral"}, {"ticker": "WNC", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005346", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.011399", "ticker_sentiment_score": "0.086923", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.007357", "ticker_sentiment_label": "Neutral"}, {"ticker": "R", "relevance_score": "0.011399", "ticker_sentiment_score": "0.025286", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.001017", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002475", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.026008", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000679", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000732", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRDA", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.029336", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBCI", "relevance_score": "0.011399", "ticker_sentiment_score": "0.00521", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005914", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.004488", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005938", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIL", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.004828", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.011399", "ticker_sentiment_score": "0.003033", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.011399", "ticker_sentiment_score": "0.003303", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTHM", "relevance_score": "0.011399", "ticker_sentiment_score": "0.002378", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.00047", "ticker_sentiment_label": "Neutral"}, {"ticker": "MHLD", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005755", "ticker_sentiment_label": "Neutral"}, {"ticker": "CREX", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000477", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRUG", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.021703", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.001985", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.008221", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZEK", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005993", "ticker_sentiment_label": "Neutral"}, {"ticker": "WSFS", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.008414", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.003143", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.025281", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000245", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPS", "relevance_score": "0.011399", "ticker_sentiment_score": "0.003919", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005313", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLCN", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002069", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002789", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLGY", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000347", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.288772", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LLAP", "relevance_score": "0.011399", "ticker_sentiment_score": "0.002326", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.022574", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLDO", "relevance_score": "0.022796", "ticker_sentiment_score": "0.007126", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTW", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.148234", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZVO", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.009961", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.011399", "ticker_sentiment_score": "0.023421", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000974", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBTX", "relevance_score": "0.011399", "ticker_sentiment_score": "0.007428", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.014198", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002367", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.016389", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIM", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.006117", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005653", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.291076", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MTEK", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.005107", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTLP", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000699", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEC", "relevance_score": "0.011399", "ticker_sentiment_score": "0.002828", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKE", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000403", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.011399", "ticker_sentiment_score": "0.004707", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.011399", "ticker_sentiment_score": "0.002009", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBCP", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.013797", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.000348", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAIN", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.025429", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.011399", "ticker_sentiment_score": "0.006593", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.020455", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.019002", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFUS", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000925", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLTR", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000661", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.011399", "ticker_sentiment_score": "0.013194", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFG", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002841", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.016941", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.008441", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVR", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.003009", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNT", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000969", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.007435", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.056949", "ticker_sentiment_score": "0.002874", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIW", "relevance_score": "0.011399", "ticker_sentiment_score": "0.00131", "ticker_sentiment_label": "Neutral"}, {"ticker": "LDI", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.001054", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGI", "relevance_score": "0.011399", "ticker_sentiment_score": "0.001632", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.011399", "ticker_sentiment_score": "0.002461", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.011399", "ticker_sentiment_score": "0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000546", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNCE", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.008273", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFIB", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.013021", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSK", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.018548", "ticker_sentiment_label": "Neutral"}, {"ticker": "FAF", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002841", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGS", "relevance_score": "0.011399", "ticker_sentiment_score": "0.001373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.011399", "ticker_sentiment_score": "0.019181", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.002211", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.011399", "ticker_sentiment_score": "-0.007736", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.011399", "ticker_sentiment_score": "0.001671", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.011399", "ticker_sentiment_score": "0.003437", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.011399", "ticker_sentiment_score": "0.000868", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences Completes Enrollment in ARCHER Phase 2 Trial of Novel C1q Inhibitor, ANX007, in Patients with Geographic Atrophy", "url": "https://www.globenewswire.com/news-release/2022/04/07/2418284/0/en/Annexon-Biosciences-Completes-Enrollment-in-ARCHER-Phase-2-Trial-of-Novel-C1q-Inhibitor-ANX007-in-Patients-with-Geographic-Atrophy.html", "time_published": "20220407T103000", "authors": ["Annexon Biosciences"], "summary": "Topline efficacy and safety data expected in first half of 2023 Topline efficacy and safety data expected in first half of 2023", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.307787, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.347432", "ticker_sentiment_score": "0.307787", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/04/26453944/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220404T160501", "authors": [], "summary": "On Monday, 78 companies set new 52-week lows.\nKey Facts About Today's 52-Week Lows:\nCitigroup  ( NYSE:C )  was the biggest company by market cap to set a new 52-week low.\nThe smallest company by market cap to set a new 52-week low was Evoke Pharma  ( NASDAQ:EVOK ) .\nCuris  ( NASDAQ:CRIS )  saw the m", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5775.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.019937, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VINC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.017247", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEIM", "relevance_score": "0.062934", "ticker_sentiment_score": "-0.032836", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBC", "relevance_score": "0.031491", "ticker_sentiment_score": "0.00058", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEX", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.032916", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.031491", "ticker_sentiment_score": "0.007118", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOOR", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.000227", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLT", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.014135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.125477", "ticker_sentiment_score": "-0.061449", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.015837", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.253181", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANNX", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.008559", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEC", "relevance_score": "0.031491", "ticker_sentiment_score": "0.002244", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBK", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.007658", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.002794", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.031491", "ticker_sentiment_score": "0.003788", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.011012", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHLD", "relevance_score": "0.031491", "ticker_sentiment_score": "0.001516", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.204262", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CLXT", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.0001", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKR", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.016899", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTH", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.008596", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLIC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.015895", "ticker_sentiment_label": "Neutral"}, {"ticker": "B", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.00053", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.062934", "ticker_sentiment_score": "0.022033", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.031491", "ticker_sentiment_score": "0.00439", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTIC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.292684", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRIS", "relevance_score": "0.062934", "ticker_sentiment_score": "-0.006307", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.031491", "ticker_sentiment_score": "0.020163", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCCO", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.0064", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.031491", "ticker_sentiment_score": "0.001199", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.031491", "ticker_sentiment_score": "0.003996", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.062934", "ticker_sentiment_score": "0.00096", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.007292", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLN", "relevance_score": "0.031491", "ticker_sentiment_score": "0.002667", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFIB", "relevance_score": "0.031491", "ticker_sentiment_score": "0.000889", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.014742", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPBI", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.202661", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WDFC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.01193", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.003775", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.062934", "ticker_sentiment_score": "0.018504", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.217343", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RAD", "relevance_score": "0.031491", "ticker_sentiment_score": "0.004415", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSCP", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.000827", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.031491", "ticker_sentiment_score": "0.004848", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZO", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.006225", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.031491", "ticker_sentiment_score": "0.003408", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLB", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.003367", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVS", "relevance_score": "0.031491", "ticker_sentiment_score": "0.014542", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.000502", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.031491", "ticker_sentiment_score": "0.001664", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Participate in the 21st Annual Needham Virtual Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/04/04/2415510/0/en/Annexon-Biosciences-to-Participate-in-the-21st-Annual-Needham-Virtual-Healthcare-Conference.html", "time_published": "20220404T103000", "authors": ["Annexon Biosciences"], "summary": "CAMBRIDGE, Mass., April  04, 2022   ( GLOBE NEWSWIRE )  -- Annexon, Inc.  ( Nasdaq: ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announc", "banner_image": "https://ml.globenewswire.com/Resource/Download/fda933a1-e95d-4cae-8894-7b2354118e20?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.034113, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.702913", "ticker_sentiment_score": "0.034113", "ticker_sentiment_label": "Neutral"}]}, {"title": "Annexon Biosciences to Participate in the 21st Annual Needham Virtual Healthcare Conference", "url": "https://www.benzinga.com/pressreleases/22/04/g26444887/annexon-biosciences-to-participate-in-the-21st-annual-needham-virtual-healthcare-conference", "time_published": "20220404T103000", "authors": ["Globe Newswire"], "summary": "CAMBRIDGE, Mass., April  04, 2022   ( GLOBE NEWSWIRE )  -- Annexon, Inc.  ( NASDAQ:ANNX ) , a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announce", "banner_image": "https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.033066, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.668612", "ticker_sentiment_score": "0.049633", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/news/22/04/26425809/stocks-that-hit-52-week-lows-on-friday", "time_published": "20220401T170001", "authors": [], "summary": "On Friday, 111 companies set new 52-week lows.\nInteresting Points From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Citigroup  ( NYSE:C ) .\nGeovax Labs  ( NASDAQ:GOVX )  was the smallest firm by market cap to set a new 52-week low.\nSELLAS Life Sciences Gr  ( N", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5685.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.015894, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MTH", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000861", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.198155", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GRPH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006129", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.021113", "ticker_sentiment_score": "0.004066", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000111", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.042211", "ticker_sentiment_score": "-0.121553", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLAP", "relevance_score": "0.021113", "ticker_sentiment_score": "0.007685", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.017968", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006299", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.021113", "ticker_sentiment_score": "0.001952", "ticker_sentiment_label": "Neutral"}, {"ticker": "PATK", "relevance_score": "0.021113", "ticker_sentiment_score": "0.016351", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.013715", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTW", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.021113", "ticker_sentiment_score": "0.006592", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002831", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.009276", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.042211", "ticker_sentiment_score": "-0.047335", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKE", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006079", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00889", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002155", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00755", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.016182", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.021707", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTLD", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001305", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.013715", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.026488", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.010823", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.009254", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.021113", "ticker_sentiment_score": "-9.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKOH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.150414", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "POWL", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000735", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.021113", "ticker_sentiment_score": "0.020215", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.021113", "ticker_sentiment_score": "0.020126", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000387", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00077", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002867", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.004158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.009071", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.004525", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002073", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.005319", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.06328", "ticker_sentiment_score": "0.016609", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.021113", "ticker_sentiment_score": "0.0243", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006704", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.011622", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002989", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVE", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000119", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSA", "relevance_score": "0.042211", "ticker_sentiment_score": "-0.026398", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.021113", "ticker_sentiment_score": "-3.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000928", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.021113", "ticker_sentiment_score": "0.010369", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.021113", "ticker_sentiment_score": "0.001864", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002127", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.217771", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PHM", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.156253", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CWH", "relevance_score": "0.021113", "ticker_sentiment_score": "0.001797", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.021113", "ticker_sentiment_score": "2.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.021113", "ticker_sentiment_score": "0.012276", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLN", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.050685", "ticker_sentiment_label": "Neutral"}, {"ticker": "THO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000532", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.021113", "ticker_sentiment_score": "0.007954", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001182", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFIB", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000574", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000606", "ticker_sentiment_label": "Neutral"}, {"ticker": "WNW", "relevance_score": "0.021113", "ticker_sentiment_score": "0.002408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.023036", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAB", "relevance_score": "0.021113", "ticker_sentiment_score": "0.005009", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSTR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.003393", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001325", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.035112", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYTS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.214347", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.007266", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001657", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAD", "relevance_score": "0.021113", "ticker_sentiment_score": "0.004367", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSCP", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002927", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.005786", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00445", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.005656", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZO", "relevance_score": "0.021113", "ticker_sentiment_score": "0.016823", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.023391", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.353061", "ticker_sentiment_label": "Bearish"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/news/22/03/26401822/stocks-that-hit-52-week-lows-on-thursday", "time_published": "20220331T181044", "authors": [], "summary": "On Thursday, 92 companies hit new 52-week lows.\nAreas of Interest About Today's 52-Week Lows:\nThe largest company in terms of market cap to set a new 52-week low was UiPath  ( NYSE:PATH ) .\nThe smallest company by market cap to set a new 52-week low was Stryve Foods  ( NASDAQ:SNAX ) .\nMotorsport Gam", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5580.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.001059, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MTH", "relevance_score": "0.02511", "ticker_sentiment_score": "0.006838", "ticker_sentiment_label": "Neutral"}, {"ticker": "PATH", "relevance_score": "0.02511", "ticker_sentiment_score": "0.026483", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.014045", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.02511", "ticker_sentiment_score": "0.013945", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.0019", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.02511", "ticker_sentiment_score": "0.029993", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.02511", "ticker_sentiment_score": "0.002284", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.006696", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.01472", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001113", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGI", "relevance_score": "0.02511", "ticker_sentiment_score": "0.008988", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.155634", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ADAG", "relevance_score": "0.02511", "ticker_sentiment_score": "0.001066", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.020873", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.006959", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.02511", "ticker_sentiment_score": "-9.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.006173", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000273", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.021348", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.005365", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGF", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.016643", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.050196", "ticker_sentiment_score": "0.017922", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.025102", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.02511", "ticker_sentiment_score": "0.005197", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.02511", "ticker_sentiment_score": "0.001503", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEC", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.002252", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.02511", "ticker_sentiment_score": "-5.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.004309", "ticker_sentiment_label": "Neutral"}, {"ticker": "POWL", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.004439", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.009635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNSO", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.029687", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.233716", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "XBIT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000461", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001591", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.029899", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001965", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.013543", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVE", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.003776", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000663", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000363", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.003305", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.011112", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASUR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.278331", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IXHL", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.005271", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000209", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRBK", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001224", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.25481", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "THO", "relevance_score": "0.02511", "ticker_sentiment_score": "0.00196", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.02511", "ticker_sentiment_score": "0.004944", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.010579", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.009057", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.02511", "ticker_sentiment_score": "0.008903", "ticker_sentiment_label": "Neutral"}, {"ticker": "CXDO", "relevance_score": "0.02511", "ticker_sentiment_score": "0.568918", "ticker_sentiment_label": "Bullish"}, {"ticker": "PYXS", "relevance_score": "0.02511", "ticker_sentiment_score": "0.002703", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000723", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMTV", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.003724", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWM", "relevance_score": "0.02511", "ticker_sentiment_score": "-6.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.004098", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGRX", "relevance_score": "0.02511", "ticker_sentiment_score": "0.019169", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.025521", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000152", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.02511", "ticker_sentiment_score": "0.021484", "ticker_sentiment_label": "Neutral"}, {"ticker": "LZB", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000725", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLFC", "relevance_score": "0.02511", "ticker_sentiment_score": "0.003987", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.013642", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLCE", "relevance_score": "0.02511", "ticker_sentiment_score": "0.006148", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMBCV", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.015329", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.01874", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/news/22/03/26376884/stocks-that-hit-52-week-lows-on-wednesday", "time_published": "20220330T164203", "authors": [], "summary": "On Wednesday, 29 stocks hit new 52-week lows.\nInteresting Points From Today's 52-Week Lows:\nThe largest company in terms of market cap to set a new 52-week low was Tempur Sealy Intl  ( NYSE:TPX ) .\nStryve Foods  ( NASDAQ:SNAX )  was the smallest company when considering market cap to set a new 52-we", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5476.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.910869"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}], "overall_sentiment_score": 0.001653, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AVAH", "relevance_score": "0.067177", "ticker_sentiment_score": "0.001524", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.000829", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.027664", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.071211", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.000789", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.000258", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.209507", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANGH", "relevance_score": "0.067177", "ticker_sentiment_score": "0.003922", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.133878", "ticker_sentiment_score": "-0.003208", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGM", "relevance_score": "0.067177", "ticker_sentiment_score": "0.005839", "ticker_sentiment_label": "Neutral"}, {"ticker": "JVA", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.00034", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.035296", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.133878", "ticker_sentiment_score": "0.041067", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.067177", "ticker_sentiment_score": "0.013355", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.000748", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.133878", "ticker_sentiment_score": "0.032893", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.067177", "ticker_sentiment_score": "-0.024134", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMBCV", "relevance_score": "0.067177", "ticker_sentiment_score": "0.000746", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.133878", "ticker_sentiment_score": "0.017029", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Tuesday", "url": "https://www.benzinga.com/news/22/03/26352676/stocks-that-hit-52-week-lows-on-tuesday", "time_published": "20220329T154325", "authors": [], "summary": "On Tuesday, 81 stocks hit new 52-week lows.\nNoteworthy Points From Today's 52-Week Lows:\nGrupo Aval Acciones  ( NYSE:AVAL )  was the biggest company by market cap to set a new 52-week low.\nThe company with the smallest market cap to set a new 52-week low was Statera BioPharma  ( NASDAQ:STAB ) .\nNeoG", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5374.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.01419, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.324602", "ticker_sentiment_score": "0.004124", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.014898", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.204038", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GALT", "relevance_score": "0.027837", "ticker_sentiment_score": "0.003868", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.37855", "ticker_sentiment_label": "Bearish"}, {"ticker": "VACC", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.012169", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAB", "relevance_score": "0.055641", "ticker_sentiment_score": "0.005878", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.010405", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.026142", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.005041", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.083376", "ticker_sentiment_score": "-0.090055", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.015184", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.027837", "ticker_sentiment_score": "0.220158", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IXHL", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.005478", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.027837", "ticker_sentiment_score": "0.000369", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.055641", "ticker_sentiment_score": "-0.128456", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.027837", "ticker_sentiment_score": "-6.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNO", "relevance_score": "0.027837", "ticker_sentiment_score": "0.002911", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.027837", "ticker_sentiment_score": "0.000604", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.027837", "ticker_sentiment_score": "-0.001016", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/03/26326033/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220328T154408", "authors": [], "summary": "On Monday, 147 stocks hit new 52-week lows.\nAreas of Significance In Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Stanley Black & Decker  ( NYSE:SWK ) .\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest firm by market cap to set a new 52-week low.\nAmyl", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5274.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.013237, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "ALNA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.007841", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTH", "relevance_score": "0.016131", "ticker_sentiment_score": "0.006178", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.016131", "ticker_sentiment_score": "0.00292", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.001019", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.002235", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00129", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001166", "ticker_sentiment_label": "Neutral"}, {"ticker": "MG", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00129", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEIP", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.01024", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.006207", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.005265", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERY", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001016", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHR", "relevance_score": "0.016131", "ticker_sentiment_score": "0.004099", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMLX", "relevance_score": "0.032255", "ticker_sentiment_score": "0.067314", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.050564", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.030956", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.01146", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.005223", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.009079", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001551", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMT", "relevance_score": "0.016131", "ticker_sentiment_score": "0.002616", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.016131", "ticker_sentiment_score": "0.035428", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.014571", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.016131", "ticker_sentiment_score": "0.023583", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.011561", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001323", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.201749", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BCAB", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00839", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.032255", "ticker_sentiment_score": "0.031252", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.007435", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.016131", "ticker_sentiment_score": "0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.23832", "ticker_sentiment_score": "-0.014788", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.017216", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.019198", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.19758", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GFF", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.294012", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BTTX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.395066", "ticker_sentiment_label": "Bearish"}, {"ticker": "CRMT", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.001846", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000394", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLXA", "relevance_score": "0.016131", "ticker_sentiment_score": "0.017783", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.096555", "ticker_sentiment_score": "0.055625", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.016131", "ticker_sentiment_score": "0.003778", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.016131", "ticker_sentiment_score": "0.014828", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001961", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBH", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.016131", "ticker_sentiment_score": "0.001423", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.016131", "ticker_sentiment_score": "0.003775", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLYB", "relevance_score": "0.016131", "ticker_sentiment_score": "0.002161", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.015082", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.016131", "ticker_sentiment_score": "7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.027164", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.016131", "ticker_sentiment_score": "0.046859", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.016131", "ticker_sentiment_score": "0.003925", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.016131", "ticker_sentiment_score": "0.00026", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIGL", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.008789", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.016131", "ticker_sentiment_score": "0.000445", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000798", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMDX", "relevance_score": "0.016131", "ticker_sentiment_score": "0.025218", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.00383", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICVX", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.026081", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIR", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.000993", "ticker_sentiment_label": "Neutral"}, {"ticker": "WGO", "relevance_score": "0.016131", "ticker_sentiment_score": "-6.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.016131", "ticker_sentiment_score": "-0.004458", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/news/22/03/26261101/stocks-that-hit-52-week-lows-on-wednesday", "time_published": "20220323T154749", "authors": [], "summary": "On Wednesday, 63 companies set new 52-week lows.\nNoteworthy Mentions In Today's 52-Week Lows:\nThe largest company by market cap to hit a new 52-week low was Stanley Black & Decker  ( NYSE:SWK ) .\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest company when considering market cap to set a n", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_4959.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.002898, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BLK", "relevance_score": "0.10342", "ticker_sentiment_score": "-0.000605", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.041653", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIQT", "relevance_score": "0.03456", "ticker_sentiment_score": "0.00171", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.003041", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.000307", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.069054", "ticker_sentiment_score": "-0.021784", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPO", "relevance_score": "0.03456", "ticker_sentiment_score": "0.004209", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000611", "ticker_sentiment_label": "Neutral"}, {"ticker": "AJX", "relevance_score": "0.03456", "ticker_sentiment_score": "0.169636", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TBBK", "relevance_score": "0.03456", "ticker_sentiment_score": "0.018846", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLR", "relevance_score": "0.03456", "ticker_sentiment_score": "2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.038025", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIASP", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.002116", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.03456", "ticker_sentiment_score": "0.004306", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.024436", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.010575", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUET", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.001794", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.01189", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.03456", "ticker_sentiment_score": "0.018846", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLYB", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.001363", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLKN", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.003568", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.03456", "ticker_sentiment_score": "0.045234", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWAQR", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.17225", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANNX", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.030484", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIL", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.030295", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.009163", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.03456", "ticker_sentiment_score": "0.006613", "ticker_sentiment_label": "Neutral"}, {"ticker": "POWL", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000623", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNE", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.001947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.000403", "ticker_sentiment_label": "Neutral"}, {"ticker": "USNA", "relevance_score": "0.03456", "ticker_sentiment_score": "0.006613", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARAY", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.021062", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGIH", "relevance_score": "0.03456", "ticker_sentiment_score": "-0.238618", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VLON", "relevance_score": "0.069054", "ticker_sentiment_score": "0.040022", "ticker_sentiment_label": "Neutral"}, {"ticker": "WGO", "relevance_score": "0.03456", "ticker_sentiment_score": "0.000919", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Tuesday", "url": "https://www.benzinga.com/news/22/03/26148458/stocks-that-hit-52-week-lows-on-tuesday", "time_published": "20220315T163235", "authors": [], "summary": "During Tuesday's session, 454 stocks hit new 52-week lows.\nIntriguing Points From Today's 52-Week Lows:\nTaiwan Semiconductor  ( NYSE:TSM )  was the largest company by market cap to set a new 52-week low.\nDermata Therapeutics  ( NASDAQ:DRMA )  was the smallest firm by market cap to set a new 52-week ", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_4337.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.014665, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.005785", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANIX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.007852", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADVM", "relevance_score": "0.00539", "ticker_sentiment_score": "0.016663", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.015636", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIGR", "relevance_score": "0.00539", "ticker_sentiment_score": "-6.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.005013", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001655", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.01134", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNET", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00158", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTGN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.010128", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUOL", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001068", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.006584", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000365", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.00539", "ticker_sentiment_score": "0.002428", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000226", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRIO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00975", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIASP", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001245", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMSI", "relevance_score": "0.00539", "ticker_sentiment_score": "-5.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVCN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003441", "ticker_sentiment_label": "Neutral"}, {"ticker": "QH", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003319", "ticker_sentiment_label": "Neutral"}, {"ticker": "COUP", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000416", "ticker_sentiment_label": "Neutral"}, {"ticker": "XMTR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.023869", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.016908", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.00539", "ticker_sentiment_score": "0.004007", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00249", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLCT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.027557", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBOX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.016265", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.004009", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002011", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOXC", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002601", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003026", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSTX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.288388", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "REED", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000856", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000399", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLYYY", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003968", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.00539", "ticker_sentiment_score": "-8.5e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLK", "relevance_score": "0.00539", "ticker_sentiment_score": "0.004362", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTE", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00062", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002042", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.005077", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.00539", "ticker_sentiment_score": "0.005028", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRG", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00648", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.00539", "ticker_sentiment_score": "0.010847", "ticker_sentiment_label": "Neutral"}, {"ticker": "COGT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.007013", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.018794", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRMT", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003426", "ticker_sentiment_label": "Neutral"}, {"ticker": "VICR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003384", "ticker_sentiment_label": "Neutral"}, {"ticker": "YRD", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.010748", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCM", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003685", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOMR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000555", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREE", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.02838", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000467", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.009918", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOHU", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001682", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003715", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001977", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDP", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000262", "ticker_sentiment_label": "Neutral"}, {"ticker": "YALA", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00351", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZTO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000687", "ticker_sentiment_label": "Neutral"}, {"ticker": "TURN", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001656", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGC", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.013482", "ticker_sentiment_label": "Neutral"}, {"ticker": "CD", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000792", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRAP", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000728", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTS", "relevance_score": "0.00539", "ticker_sentiment_score": "0.02755", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVLR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001292", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000727", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAB", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAA", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.033054", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.00539", "ticker_sentiment_score": "0.028609", "ticker_sentiment_label": "Neutral"}, {"ticker": "CO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.004424", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00341", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNES", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00615", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.015652", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCPS", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000178", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGMK", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.01306", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003151", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAOS", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001106", "ticker_sentiment_label": "Neutral"}, {"ticker": "EZGO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003949", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALZN", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001652", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRMA", "relevance_score": "0.01078", "ticker_sentiment_score": "0.02191", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.00539", "ticker_sentiment_score": "0.011856", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMWB", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003163", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATIP", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00358", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZOO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002037", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.013596", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00241", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.00539", "ticker_sentiment_score": "0.005086", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003349", "ticker_sentiment_label": "Neutral"}, {"ticker": "DQ", "relevance_score": "0.00539", "ticker_sentiment_score": "0.010578", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000506", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003681", "ticker_sentiment_label": "Neutral"}, {"ticker": "DT", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000611", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00021", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.006417", "ticker_sentiment_label": "Neutral"}, {"ticker": "EWTX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002778", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENG", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.012944", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.00539", "ticker_sentiment_score": "0.002992", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.256321", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EA", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000107", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTHX", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003043", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000671", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000893", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABA", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001224", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.00539", "ticker_sentiment_score": "0.007008", "ticker_sentiment_label": "Neutral"}, {"ticker": "EH", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.015791", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEJU", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.008334", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.038652", "ticker_sentiment_label": "Neutral"}, {"ticker": "POSH", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000597", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.009145", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVGW", "relevance_score": "0.00539", "ticker_sentiment_score": "0.002108", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.244139", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MBRX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002485", "ticker_sentiment_label": "Neutral"}, {"ticker": "TZOO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001136", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBIO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002525", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003024", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAXX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.018378", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.01078", "ticker_sentiment_score": "-0.004337", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPAY", "relevance_score": "0.00539", "ticker_sentiment_score": "0.002379", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDD", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000296", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.201144", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HUIZ", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.006352", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000753", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCTY", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000167", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000449", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.024696", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.00539", "ticker_sentiment_score": "0.005918", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000579", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.278183", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BSGM", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000367", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.006697", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.218191", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIGL", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000144", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001392", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXRX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.007141", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGNI", "relevance_score": "0.00539", "ticker_sentiment_score": "0.041719", "ticker_sentiment_label": "Neutral"}, {"ticker": "APTO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.235162", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DNA", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001144", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003308", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLO", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000337", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.015052", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIRO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00488", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTD", "relevance_score": "0.00539", "ticker_sentiment_score": "0.022561", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMACU", "relevance_score": "0.01078", "ticker_sentiment_score": "0.010717", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.01091", "ticker_sentiment_label": "Neutral"}, {"ticker": "INZY", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003561", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.017674", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.008867", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001579", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRSR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00463", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTSI", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.006936", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.020001", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHS", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001841", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001509", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRBU", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.004198", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLMD", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00634", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.00539", "ticker_sentiment_score": "0.006473", "ticker_sentiment_label": "Neutral"}, {"ticker": "YY", "relevance_score": "0.00539", "ticker_sentiment_score": "0.005034", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.00539", "ticker_sentiment_score": "0.018351", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.020278", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWP", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001238", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00451", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAOP", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003262", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00726", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.006982", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.00539", "ticker_sentiment_score": "0.002581", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.00539", "ticker_sentiment_score": "0.034498", "ticker_sentiment_label": "Neutral"}, {"ticker": "UXIN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.030859", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.207469", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LHDX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.007303", "ticker_sentiment_label": "Neutral"}, {"ticker": "APVO", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000848", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.005305", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOMD", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000683", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTWK", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001293", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.053863", "ticker_sentiment_score": "-0.065916", "ticker_sentiment_label": "Neutral"}, {"ticker": "JFIN", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000341", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001793", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOTU", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00378", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000225", "ticker_sentiment_label": "Neutral"}, {"ticker": "RGTI", "relevance_score": "0.00539", "ticker_sentiment_score": "0.004047", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001831", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOM", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.007444", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNET", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.010732", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.01709", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.009129", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMB", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.005225", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001275", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSVT", "relevance_score": "0.00539", "ticker_sentiment_score": "0.014592", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000201", "ticker_sentiment_label": "Neutral"}, {"ticker": "PINS", "relevance_score": "0.00539", "ticker_sentiment_score": "0.012104", "ticker_sentiment_label": "Neutral"}, {"ticker": "IGMS", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.0111", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFY", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.008529", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.00539", "ticker_sentiment_score": "0.002445", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000219", "ticker_sentiment_label": "Neutral"}, {"ticker": "SELB", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003321", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUYA", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.016978", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPH", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000725", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.004191", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIK", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002799", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.024354", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00478", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003888", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.379821", "ticker_sentiment_label": "Bearish"}, {"ticker": "NEO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002817", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.014926", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTEX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.040208", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAL", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000816", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVCO", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001435", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOTV", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000918", "ticker_sentiment_label": "Neutral"}, {"ticker": "RERE", "relevance_score": "0.00539", "ticker_sentiment_score": "0.005445", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.013886", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTP", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.017637", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.011087", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.00539", "ticker_sentiment_score": "0.002373", "ticker_sentiment_label": "Neutral"}, {"ticker": "LX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.012095", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.00539", "ticker_sentiment_score": "0.023298", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGBX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.252931", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "QTRX", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003169", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTIL", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002454", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNH", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.021871", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAG", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTKB", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.003494", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.025796", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.004971", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.00539", "ticker_sentiment_score": "0.035944", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.007253", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00471", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.016612", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.008116", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.00449", "ticker_sentiment_label": "Neutral"}, {"ticker": "MQ", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001006", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.00539", "ticker_sentiment_score": "0.004402", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.00539", "ticker_sentiment_score": "0.007427", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASPU", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.015519", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEAV", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.011576", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.00539", "ticker_sentiment_score": "0.009622", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.00539", "ticker_sentiment_score": "0.006156", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVK", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003968", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000248", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.00539", "ticker_sentiment_score": "0.001705", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000189", "ticker_sentiment_label": "Neutral"}, {"ticker": "STNEV", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.007007", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001284", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.00539", "ticker_sentiment_score": "0.000448", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000206", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNCR", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000419", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDL", "relevance_score": "0.00539", "ticker_sentiment_score": "-8.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFH", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.024986", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.00539", "ticker_sentiment_score": "0.012551", "ticker_sentiment_label": "Neutral"}, {"ticker": "VKTX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.010974", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.00539", "ticker_sentiment_score": "0.00543", "ticker_sentiment_label": "Neutral"}, {"ticker": "UFI", "relevance_score": "0.00539", "ticker_sentiment_score": "0.003482", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLV", "relevance_score": "0.01078", "ticker_sentiment_score": "-0.003568", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.00539", "ticker_sentiment_score": "0.018013", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIPS", "relevance_score": "0.00539", "ticker_sentiment_score": "0.013114", "ticker_sentiment_label": "Neutral"}, {"ticker": "QFIN", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001339", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVRX", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.228388", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VIOT", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.011617", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.017865", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIU", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.000627", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNO", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.001198", "ticker_sentiment_label": "Neutral"}, {"ticker": "APM", "relevance_score": "0.00539", "ticker_sentiment_score": "-0.002946", "ticker_sentiment_label": "Neutral"}]}, {"title": "MiroBio Continues Expansion of Executive Leadership Team with Key Appointments to Advance Development of Checkpoint Agonist Antibodies for Autoimmune Disease", "url": "https://www.benzinga.com/pressreleases/22/03/g26034189/mirobio-continues-expansion-of-executive-leadership-team-with-key-appointments-to-advance-developm", "time_published": "20220308T113000", "authors": [], "summary": "Sanjay Keswani, MBBS, FRCP to join company as Chief Medical Officer bringing extensive experience in drug development and life sciences leadership\nLynne Murray, Ph.D., MBA appointed as Chief Scientific Officer after leading MiroBio's R&D efforts since October 2020\nEnhanced leadership team will suppo", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "1.0"}], "overall_sentiment_score": 0.170835, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "ANNX", "relevance_score": "0.046724", "ticker_sentiment_score": "0.170835", "ticker_sentiment_label": "Somewhat-Bullish"}]}]}